<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="nihpa"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC5828950/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828950/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Clinical pharmacology and therapeutics"><meta name="citation_title" content="Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes"><meta name="citation_authors" content="Daniel M. Rotroff, Sonja S. Pijut, Skylar W. Marvel, John R. Jack, Tammy M. Havener, Aurora Pujol, Agatha Schluter, Gregory A. Graf, Henry N. Ginsberg, Hetal S. Shah, He Gao, Mario-Luca Morieri, Alessandro Doria, Josyf C. Mychaleckyi, Howard L. McLeod, John B. Buse, Michael J. Wagner, Alison A. Motsinger-Reif, the ACCORD/ACCORDion Investigators"><meta name="citation_date" content="April 2018"><meta name="citation_issue" content="4"><meta name="citation_volume" content="103"><meta name="citation_firstpage" content="712"><meta name="citation_doi" content="10.1002/cpt.798"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC5828950/?report=abstract"><meta name="citation_pmid" content="28736931"><meta name="DC.Title" content="Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="NIH Public Access"><meta name="DC.Contributor" content="Daniel M. Rotroff"><meta name="DC.Contributor" content="Sonja S. Pijut"><meta name="DC.Contributor" content="Skylar W. Marvel"><meta name="DC.Contributor" content="John R. Jack"><meta name="DC.Contributor" content="Tammy M. Havener"><meta name="DC.Contributor" content="Aurora Pujol"><meta name="DC.Contributor" content="Agatha Schluter"><meta name="DC.Contributor" content="Gregory A. Graf"><meta name="DC.Contributor" content="Henry N. Ginsberg"><meta name="DC.Contributor" content="Hetal S. Shah"><meta name="DC.Contributor" content="He Gao"><meta name="DC.Contributor" content="Mario-Luca Morieri"><meta name="DC.Contributor" content="Alessandro Doria"><meta name="DC.Contributor" content="Josyf C. Mychaleckyi"><meta name="DC.Contributor" content="Howard L. McLeod"><meta name="DC.Contributor" content="John B. Buse"><meta name="DC.Contributor" content="Michael J. Wagner"><meta name="DC.Contributor" content="Alison A. Motsinger-Reif"><meta name="DC.Contributor" content="the ACCORD/ACCORDion Investigators"><meta name="DC.Date" content="2018 Apr"><meta name="DC.Identifier" content="10.1002/cpt.798"><meta name="DC.Language" content="en"><meta property="og:title" content="Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes"><meta property="og:type" content="article"><meta property="og:description" content="Individuals with type 2 diabetes (T2D) and dyslipidemia are at an increased risk of cardiovascular disease. Fibrates are a class of drugs prescribed to treat dyslipidemia, but variation in response has been observed. To evaluate common and rare genetic ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828950/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC5828950/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC5828950/pdf/nihms921427.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8D05E3DD5A78D10000000004DD02E5.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/jax/element/mml/jax.js?rev=2.6.1"></script><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/jax/input/MathML/jax.js?rev=2.6.1"></script><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/jax/output/HTML-CSS/jax.js?rev=2.6.1"></script></head>
    <body class="article" id="ui-ncbiexternallink-4"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5828950%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed">PubMed</option><option value="nuccore">Nucleotide</option><option value="books" class="last">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC5828950</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html"><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Clin Pharmacol Ther</a></span>. Author manuscript; available in PMC 2019 Apr 1.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=28736931" target="pmc_ext" ref="reftype=publisher&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access"><span class="cit">Clin Pharmacol Ther. 2018 Apr; 103(4): 712–721. </span></a></div><span class="fm-vol-iss-date">Published online 2017 Nov 3. </span> <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1002%2Fcpt.798" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1002/cpt.798</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC5828950</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS921427</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/28736931">28736931</a></div></div></div></div><h1 class="content-title">Genetic Variants in <em>HSD17B3</em>, <em>SMAD3</em>, and <em>IPO11</em> Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Rotroff%20DM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931" class="affpopup" co-rid="_co_idm139874147491648" co-class="co-affbox">Daniel M. Rotroff</a>,<sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Pijut%20SS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931" class="affpopup" co-rid="_co_idm139874144932352" co-class="co-affbox">Sonja S. Pijut</a>,<sup>3</sup> <a href="/pubmed/?term=Marvel%20SW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931" class="affpopup" co-rid="_co_idm139874144930704" co-class="co-affbox">Skylar W. Marvel</a>,<sup>1</sup> <a href="/pubmed/?term=Jack%20JR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931" class="affpopup" co-rid="_co_idm139874144928720" co-class="co-affbox">John R. Jack</a>,<sup>1</sup> <a href="/pubmed/?term=Havener%20TM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931" class="affpopup" co-rid="_co_idm139874144926736" co-class="co-affbox">Tammy M. Havener</a>,<sup>4</sup> <a href="/pubmed/?term=Pujol%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931" class="affpopup" co-rid="_co_idm139874151369360" co-class="co-affbox">Aurora Pujol</a>,<sup>5,</sup><sup>6</sup> <a href="/pubmed/?term=Schluter%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931" class="affpopup" co-rid="_co_idm139874151366640" co-class="co-affbox">Agatha Schluter</a>,<sup>5</sup> <a href="/pubmed/?term=Graf%20GA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931" class="affpopup" co-rid="_co_idm139874151364656" co-class="co-affbox">Gregory A. Graf</a>,<sup>3,</sup><sup>7,</sup><sup>8</sup> <a href="/pubmed/?term=Ginsberg%20HN%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931" class="affpopup" co-rid="_co_idm139874149128544" co-class="co-affbox">Henry N. Ginsberg</a>,<sup>9</sup> <a href="/pubmed/?term=Shah%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931" class="affpopup" co-rid="_co_idm139874149126560" co-class="co-affbox">Hetal S. Shah</a>,<sup>10</sup> <a href="/pubmed/?term=Gao%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931" class="affpopup" co-rid="_co_idm139874148963872" co-class="co-affbox">He Gao</a>,<sup>10</sup> <a href="/pubmed/?term=Morieri%20ML%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931" class="affpopup" co-rid="_co_idm139874148961888" co-class="co-affbox">Mario-Luca Morieri</a>,<sup>10</sup> <a href="/pubmed/?term=Doria%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931" class="affpopup" co-rid="_co_idm139874148959904" co-class="co-affbox">Alessandro Doria</a>,<sup>10</sup> <a href="/pubmed/?term=Mychaleckyi%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931" class="affpopup" co-rid="_co_idm139874148984336" co-class="co-affbox">Josyf C. Mychaleckyi</a>,<sup>11</sup> <a href="/pubmed/?term=McLeod%20HL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931" class="affpopup" co-rid="_co_idm139874148982352" co-class="co-affbox">Howard L. McLeod</a>,<sup>12</sup> <a href="/pubmed/?term=Buse%20JB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931" class="affpopup" co-rid="_co_idm139874148980368" co-class="co-affbox">John B. Buse</a>,<sup>13</sup> <a href="/pubmed/?term=Wagner%20MJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931" class="affpopup" co-rid="_co_idm139874148978384" co-class="co-affbox">Michael J. Wagner</a>,<sup>4</sup> <a href="/pubmed/?term=Motsinger-Reif%20AA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931" class="affpopup" co-rid="_co_idm139874154182224" co-class="co-affbox">Alison A. Motsinger-Reif</a>,<sup>1,</sup><sup>2</sup> and  the ACCORD/ACCORDion Investigators</div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139874147491648"><h3 class="no_margin">Daniel M. Rotroff</h3><p>  <sup>1</sup>Bioinformatics Research Center, North Carolina State University, Raleigh, North Carolina, USA</p><p>  <sup>2</sup>Department of Statistics, North Carolina State University, Raleigh, North Carolina, USA</p><div>Find articles by <a href="/pubmed/?term=Rotroff%20DM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931">Daniel M. Rotroff</a></div></div><div id="_co_idm139874144932352"><h3 class="no_margin">Sonja S. Pijut</h3><p>  <sup>3</sup>Department of Pharmaceutical Sciences, University of Kentucky, Lexington, Kentucky, USA</p><div>Find articles by <a href="/pubmed/?term=Pijut%20SS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931">Sonja S. Pijut</a></div></div><div id="_co_idm139874144930704"><h3 class="no_margin">Skylar W. Marvel</h3><p>  <sup>1</sup>Bioinformatics Research Center, North Carolina State University, Raleigh, North Carolina, USA</p><div>Find articles by <a href="/pubmed/?term=Marvel%20SW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931">Skylar W. Marvel</a></div></div><div id="_co_idm139874144928720"><h3 class="no_margin">John R. Jack</h3><p>  <sup>1</sup>Bioinformatics Research Center, North Carolina State University, Raleigh, North Carolina, USA</p><div>Find articles by <a href="/pubmed/?term=Jack%20JR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931">John R. Jack</a></div></div><div id="_co_idm139874144926736"><h3 class="no_margin">Tammy M. Havener</h3><p>  <sup>4</sup>Center for Pharmacogenomics and Individualized Therapy, University of North Carolina Chapel Hill, Chapel Hill, North Carolina, USA</p><div>Find articles by <a href="/pubmed/?term=Havener%20TM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931">Tammy M. Havener</a></div></div><div id="_co_idm139874151369360"><h3 class="no_margin">Aurora Pujol</h3><p>  <sup>5</sup>Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), and CIBERER U759, Center for Biomedical Research on Rare Diseases, Barcelona, Spain</p><p>  <sup>6</sup>Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain</p><div>Find articles by <a href="/pubmed/?term=Pujol%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931">Aurora Pujol</a></div></div><div id="_co_idm139874151366640"><h3 class="no_margin">Agatha Schluter</h3><p>  <sup>5</sup>Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), and CIBERER U759, Center for Biomedical Research on Rare Diseases, Barcelona, Spain</p><div>Find articles by <a href="/pubmed/?term=Schluter%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931">Agatha Schluter</a></div></div><div id="_co_idm139874151364656"><h3 class="no_margin">Gregory A. Graf</h3><p>  <sup>3</sup>Department of Pharmaceutical Sciences, University of Kentucky, Lexington, Kentucky, USA</p><p>  <sup>7</sup>Center for Pharmaceutical Research and Innovation, University of Kentucky, Lexington, Kentucky, USA</p><p>  <sup>8</sup>Saha Cardiovascular Research Center, University of Kentucky, Lexington, Kentucky, USA</p><div>Find articles by <a href="/pubmed/?term=Graf%20GA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931">Gregory A. Graf</a></div></div><div id="_co_idm139874149128544"><h3 class="no_margin">Henry N. Ginsberg</h3><p>  <sup>9</sup>Irving Institute for Clinical and Translational Research, Columbia University College of Physicians and Surgeons, New York, New York, USA</p><div>Find articles by <a href="/pubmed/?term=Ginsberg%20HN%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931">Henry N. Ginsberg</a></div></div><div id="_co_idm139874149126560"><h3 class="no_margin">Hetal S. Shah</h3><p>  <sup>10</sup>Joslin Diabetes Center and Harvard Medical School, Boston, Massachusetts, USA</p><div>Find articles by <a href="/pubmed/?term=Shah%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931">Hetal S. Shah</a></div></div><div id="_co_idm139874148963872"><h3 class="no_margin">He Gao</h3><p>  <sup>10</sup>Joslin Diabetes Center and Harvard Medical School, Boston, Massachusetts, USA</p><div>Find articles by <a href="/pubmed/?term=Gao%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931">He Gao</a></div></div><div id="_co_idm139874148961888"><h3 class="no_margin">Mario-Luca Morieri</h3><p>  <sup>10</sup>Joslin Diabetes Center and Harvard Medical School, Boston, Massachusetts, USA</p><div>Find articles by <a href="/pubmed/?term=Morieri%20ML%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931">Mario-Luca Morieri</a></div></div><div id="_co_idm139874148959904"><h3 class="no_margin">Alessandro Doria</h3><p>  <sup>10</sup>Joslin Diabetes Center and Harvard Medical School, Boston, Massachusetts, USA</p><div>Find articles by <a href="/pubmed/?term=Doria%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931">Alessandro Doria</a></div></div><div id="_co_idm139874148984336"><h3 class="no_margin">Josyf C. Mychaleckyi</h3><p>  <sup>11</sup>Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA</p><div>Find articles by <a href="/pubmed/?term=Mychaleckyi%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931">Josyf C. Mychaleckyi</a></div></div><div id="_co_idm139874148982352"><h3 class="no_margin">Howard L. McLeod</h3><p>  <sup>12</sup>Moffitt Cancer Center, Tampa, Florida, USA</p><div>Find articles by <a href="/pubmed/?term=McLeod%20HL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931">Howard L. McLeod</a></div></div><div id="_co_idm139874148980368"><h3 class="no_margin">John B. Buse</h3><p>  <sup>13</sup>Division of Endocrinology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA</p><div>Find articles by <a href="/pubmed/?term=Buse%20JB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931">John B. Buse</a></div></div><div id="_co_idm139874148978384"><h3 class="no_margin">Michael J. Wagner</h3><p>  <sup>4</sup>Center for Pharmacogenomics and Individualized Therapy, University of North Carolina Chapel Hill, Chapel Hill, North Carolina, USA</p><div>Find articles by <a href="/pubmed/?term=Wagner%20MJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931">Michael J. Wagner</a></div></div><div id="_co_idm139874154182224"><h3 class="no_margin">Alison A. Motsinger-Reif</h3><p>  <sup>1</sup>Bioinformatics Research Center, North Carolina State University, Raleigh, North Carolina, USA</p><p>  <sup>2</sup>Department of Statistics, North Carolina State University, Raleigh, North Carolina, USA</p><div>Find articles by <a href="/pubmed/?term=Motsinger-Reif%20AA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28736931">Alison A. Motsinger-Reif</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139874151719152_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139874151719152_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139874151719152_ai" style="display:none"><div class="fm-affl" id="A1" lang="en">  <sup>1</sup>Bioinformatics Research Center, North Carolina State University, Raleigh, North Carolina, USA</div><div class="fm-affl" id="A2" lang="en">  <sup>2</sup>Department of Statistics, North Carolina State University, Raleigh, North Carolina, USA</div><div class="fm-affl" id="A3" lang="en">  <sup>3</sup>Department of Pharmaceutical Sciences, University of Kentucky, Lexington, Kentucky, USA</div><div class="fm-affl" id="A4" lang="en">  <sup>4</sup>Center for Pharmacogenomics and Individualized Therapy, University of North Carolina Chapel Hill, Chapel Hill, North Carolina, USA</div><div class="fm-affl" id="A5" lang="en">  <sup>5</sup>Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), and CIBERER U759, Center for Biomedical Research on Rare Diseases, Barcelona, Spain</div><div class="fm-affl" id="A6" lang="en">  <sup>6</sup>Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain</div><div class="fm-affl" id="A7" lang="en">  <sup>7</sup>Center for Pharmaceutical Research and Innovation, University of Kentucky, Lexington, Kentucky, USA</div><div class="fm-affl" id="A8" lang="en">  <sup>8</sup>Saha Cardiovascular Research Center, University of Kentucky, Lexington, Kentucky, USA</div><div class="fm-affl" id="A9" lang="en">  <sup>9</sup>Irving Institute for Clinical and Translational Research, Columbia University College of Physicians and Surgeons, New York, New York, USA</div><div class="fm-affl" id="A10" lang="en">  <sup>10</sup>Joslin Diabetes Center and Harvard Medical School, Boston, Massachusetts, USA</div><div class="fm-affl" id="A11" lang="en">  <sup>11</sup>Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA</div><div class="fm-affl" id="A12" lang="en">  <sup>12</sup>Moffitt Cancer Center, Tampa, Florida, USA</div><div class="fm-affl" id="A13" lang="en">  <sup>13</sup>Division of Endocrinology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA</div><div id="FN1">Correspondence: A Motsinger-Reif (<a href="mailto:dev@null" data-email="ude.uscn@regnistom_nosila" class="oemail">ude.uscn@regnistom_nosila</a>)</div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm139874151719152_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>The publisher's final edited version of this article is available  at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=28736931" target="pmc_ext" ref="reftype=publisher&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access">Clin Pharmacol Ther</a></div><div>See other articles in PMC that <a href="/pmc/articles/PMC5828950/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Supp Info.</strong></div><div><a href="/pmc/articles/PMC5828950/bin/NIHMS921427-supplement-Supp_Info.docx" data-ga-action="click_feat_suppl">NIHMS921427-supplement-Supp_Info.docx</a><span style="color:gray"> (2.8M)</span></div><div class="small guid">GUID:&nbsp;0113C08B-816F-4D5F-9479-910FB1AD5A10</div></div></dd></dl></div><div id="idm139874183967984" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139874183967984title">Abstract</h2><!--article-meta--><div><p id="P1" class="p p-first-last">Individuals with type 2 diabetes (T2D) and dyslipidemia are at an increased risk of cardiovascular disease. Fibrates are a class of drugs prescribed to treat dyslipidemia, but variation in response has been observed. To evaluate common and rare genetic variants that impact lipid responses to fenofibrate in statin-treated patients with T2D, we examined lipid changes in response to fenofibrate therapy using a genomewide association study (GWAS). Associations were followed-up using gene expression studies in mice. Common variants in <em>SMAD3</em> and <em>IPO11</em> were marginally associated with lipid changes in black subjects (<em>P</em> &lt; 5 × 10<sup>−6</sup>). Rare variant and gene expression changes were assessed using a false discovery rate approach. <em>AKR7A3</em> and <em>HSD17B13</em> were associated with lipid changes in white subjects (<em>q</em> &lt; 0.2). Mice fed fenofibrate displayed reductions in <em>Hsd17b13</em> gene expression (<em>q</em> &lt; 0.1). Associations of variants in <em>SMAD3</em>, <em>IPO11</em>, and <em>HSD17B13</em>, with gene expression changes in mice indicate that transforming growth factor-beta (TGF-β) and NRF2 signaling pathways may influence fenofibrate effects on dyslipidemia in patients with T2D.</p></div></div><div id="idm139874146554096" class="tsec sec headless whole_rhythm"><p id="P2" class="p p-first">Dyslipidemia is a significant risk factor for cardiovascular disease (CVD), which is the leading cause of death worldwide.<sup><a href="#R1" rid="R1" class=" bibr popnode">1</a></sup> In the United States, it is estimated that 33.5% of adults have high low-density lipoprotein (LDL), and only 48.1% of those individuals are currently being treated.<sup><a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881203">2</a></sup> Individuals with type 2 diabetes (T2D) commonly express a dyslipidemia, characterized by high triglycerides, low high-density lipoprotein (HDL), and an increase in cholesterol poor, small LDL, and are 2–4 times more likely to develop heart disease than nondiabetic individuals.<sup><a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881209">2</a></sup></p><p id="P3">Fibrates, a class of medications used to treat individuals with dyslipidemia by activating the peroxisome proliferator-activated receptor-alpha (PPARα), increases HDL and lowers triglycerides and LDL. Meta-analyses of several large clinical trials indicated that treatment with fibrates decrease the number of nonfatal myocardial infarctions, although they did not decrease all-cause mortality.<sup><a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881241">3</a>,<a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881220">4</a></sup> Statins are the first-line treatment to lower LDL to prevent CVD.<sup><a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881208">5</a></sup> Fibrates are generally not recommended to reduce CVD because of a lack of demonstrated benefit, although they are recommended for the management of hypertriglyceridemia.<sup><a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881231">6</a></sup> Specifically, fenofibrate is recommended in the context of statin therapy because of lower risk of interference with statin metabolism and myopathy.<sup><a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881236">5</a>,<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881218">6</a></sup></p><p id="P4">One goal of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) clinical trial was to compare the benefits and risks of treatment strategies for intensively managing dyslipidemia with a combined statin and fenofibrate therapy vs. treatment with statin alone, whereas simultaneously targeting normal glycemia and blood pressure vs. standard targets in individuals with T2D at high risk for CVD.<sup><a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881224">7</a>,<a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881200">8</a></sup> The ACCORD trial followed 10,251 participants for up to 8 years at 77 clinical centers in the United States and Canada. Overall, no statistically significant benefits were observed for patients on the combined CVD endpoint of time to first heart attack, stroke, or CVD mortality. In addition, there was an increase in mortality in participants receiving intensive glycemia control.<sup><a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881227">9</a>–<a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881229">12</a></sup> Despite the lack of overall positive findings, interindividual variation in response to the different treatments in ACCORD was observed. Such variation to fibrate lipid response has been observed in a number of studies<sup><a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881223">13</a>–<a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881219">15</a></sup> and suggests that genetic markers of drug response may be important biomarkers for more targeted and personalized treatment strategies.</p><p id="P5">Previous studies have also investigated the role of genetic variation in fibrate lipid response with the majority of studies focused on candidate gene approaches to identify common or rare variants associated with differential responses.<sup><a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881237">16</a>–<a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881216">19</a></sup> Here, we performed genomewide and exome-wide genotyping on all consenting individuals in the ACCORD study prescribed fenofibrate (<em>n</em> = 1,264). We previously reported a genomewide association study (GWAS) of fenofibrate drug response from a meta-analysis of subjects of European ancestry in ACCORD and the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) study.<sup><a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881222">14</a></sup> Here, we expand the analysis of ACCORD participants to include other ethnicities, using combined data from a genomewide single nucleotide polymorphism (SNP) array, and an exome chip array with &gt;1.2 million combined genotyped SNPs and rare variant analysis for SNPs with minor allele frequencies (MAFs) &lt;3% for changes in LDL, HDL, triglycerides (TGs), and total cholesterol (TC). Our results indicate interesting and potentially impactful associations, and we use mouse studies to test the hypotheses generated by the gene-mapping analysis. To our knowledge, this is the first GWAS of fenofibrate lipid response in multiple ethnicities, and the first exome-wide interrogation of fibrate drug response.</p><p id="P6" class="p">Although the results of the association mapping experiment can point to interesting biology, functional follow-up is a crucial step to support association analyses. In the current study, we considered the GWAS to be a hypothesis generating exercise to prioritize genes for further functional interrogation. We subsequently evaluated the genes identified through association analysis in two mouse gene expression studies, and demonstrate that many of the genes discovered in the association analysis play a significant role in fibrate drug response.</p></div><div id="S1" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S1title">RESULTS</h2><p id="P7" class="p p-first">A total of 1,264, 781, and 138 subjects were included in the common and rare variant analyses for all races combined, white, and black cohorts, respectively. Variation in response was observed for all phenotypes: HDL, LDL, TC, and TG (<a href="/pmc/articles/PMC5828950/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>). Distributions of response variation for white and black cohorts individually can be found in <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figures S1 and S2</a>. The mean change in HDL was 3.16 mg/dL (95% confidence interval [CI] = 2.78–3.53) for all races combined, 3.11 mg/dL (95% CI = 2.62–3.60) for white subjects only, and 2.80 mg/dL (95% CI = 1.73–3.86) for black subjects only. The mean change in LDL was −10.64 mg/dL (95% CI = −12.48 to −8.79) for all races combined, −9.31 mg/dL (95% CI = −11.68 to −6.95) for white subjects only, and −10.83 mg/dL (95% CI = −16.73 to −4.94) for black subjects only. The mean change in TG was −45.23 mg/dL (95% CI = −50.27 to −40.28) for all races combined, −52.04 mg/dL (95% CI = −58.31 to −45.78) for white subjects only, and −34.43 mg/dL (95% CI = −46.96 to −21.91) for black subjects only. The mean change in TC was −16.10 mg/dL (95% CI = −18.27 to −13.92) for all races combined, −16.14 mg/dL (95% CI = −18.93 to −13.35) for white subjects only, and −14.51 mg/dL (95% CI = −21.13 to −7.88) for black subjects only.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC5828950/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139874152200192" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is nihms921427f1.jpg" title="An external file that holds a picture, illustration, etc.
Object name is nihms921427f1.jpg" src="/pmc/articles/PMC5828950/bin/nihms921427f1.jpg"></div></a><div id="largeobj_idm139874152200192" class="largeobj-link align_right" style=""><a href="/pmc/articles/PMC5828950/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a target="object" href="/pmc/articles/PMC5828950/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC5828950/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p7">Distributions of fenofibrate response on lipid measurements in subjects of all combined races (<em>N</em> = 1264). (<strong>a</strong>) Log-ratio of the change in high-density lipoprotein (HDL; mg/dL). (<strong>b</strong>) Log-ratio of the change in low-density lipoprotein (LDL; mg/dL). (<strong>c</strong>) Log-ratio of the change in triglycerides (mg/dL). (<strong>d</strong>) Log-ratio of the change in total cholesterol (mg/dL).</p></div></div></div><div id="S2" class="sec"><h3 id="S2title">Common variant analysis</h3><p id="P8" class="p p-first-last">A total of 852,426 genotyped and 7,277,412 imputed variants had MAFs &gt;3% and were included in the common variant analysis. When all races were combined or white subjects were analyzed, no SNPs met the threshold for genomewide significance (<em>P</em> &lt; 5 × 10<sup>−8</sup>). When all races were combined, 8 SNPs associated with TG (genes: <em>BEST3</em>, <em>LOC105371270</em>, and <em>RPGRIP1L</em>; <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure S3</a>), 34 SNPs associated with TC (genes: <em>FGF14</em>, <em>PRRX1</em>, <em>MRPL12</em>, <em>ZNF775</em>, and <em>FBXL7</em>; <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure S4</a>), 1 SNP associated with HDL (no known genes; <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure S5</a>), and 2 SNP associated with LDL (genes: <em>FGF14</em> and <em>MRPL12</em>; <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure S6</a>) reached the threshold for suggestive significance (<em>P</em> &lt; 1 × 10<sup>−6</sup>). For white subjects only, 11 SNPs associated with TG (genes: <em>LOC105371270</em> and <em>RPGRIP1L</em>; <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure S7</a>), 11 SNPs associated with TC (genes: <em>MAU2</em> and <em>PBX4</em>; <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure S8</a>), 0 SNPs associated with HDL (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure S9</a>), and 8 SNP associated with LDL (genes: <em>PBX4</em>, <em>SNX7</em>, and <em>MAU2</em>; <a href="/pmc/articles/PMC5828950/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>) reached the threshold for suggestive significance (<em>P</em> &lt; 1 × 10<sup>−6</sup>). When black subjects were analyzed separately, 6 SNPs were significantly associated (<em>P</em> &lt; 5 × 10<sup>−8</sup>) with TG (genes: <em>LRFN2</em>, <em>LINC00333</em>, and <em>BCL9</em>), and 55 SNPs reached suggestive significance (<em>P</em> &lt; 1 × 10<sup>−6</sup>) with TG (genes: <em>GLIS3</em>, <em>CCDC149</em>, <em>LINGO2</em>, <em>SNHG17</em>, <em>LOC105370782</em>, <em>TTLL8</em>, <em>RHOBTB1</em>, and <em>LOC101927866</em>; <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure S10</a>). Seven SNPs were significantly associated (<em>P</em> &lt; 5 × 10<sup>−8</sup>) with TC (genes: <em>CLN8</em> and <em>BICC1</em>), and 108 SNPs reached suggestive significance (<em>P</em> &lt; 1 × 10<sup>−6</sup>) with TC (genes: <em>ST6GALNAC3</em>, <em>LOC105372744</em>, <em>SCGN</em>, <em>LOC102724378</em>, <em>NRXN1</em>, <em>LCT</em>, <em>LOC102724680</em>, <em>RBM19</em>, <em>MCM6</em>, <em>DARS</em>, <em>TRIOBP</em>, <em>DARS-AS1</em>, <em>PEX5L</em>, <em>LOC102724680</em>, and <em>NLGN1</em>; <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure S11</a>). One SNP was significantly associated (<em>P</em> &lt; 5 × 10<sup>−8</sup>) with HDL (gene: <em>MSH3</em>), and 8 SNPs reached suggestive significance (<em>P</em> &lt; 1 × 10<sup>−6</sup>) with HDL (genes: <em>TGFBR3</em>, <em>LOC105373670</em>, <em>STX8</em>, and <em>CELSR1</em>; <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure S12</a>). Last, 5 SNPs associated with LDL (genes: <em>BICC1</em>, <em>FOXP1</em>, and <em>PEX5L</em>; <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure S13</a>) reached the threshold for suggestive significance (<em>P</em> &lt; 1 × 10<sup>−6</sup>). Lead SNPs associated with HDL, LDL, TC, and TG (<em>P</em> &lt; 1 × 10<sup>−6</sup>) are presented in <a href="/pmc/articles/PMC5828950/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Tables 1</span></a> and <a href="/pmc/articles/PMC5828950/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span style="position: relative;text-decoration:none;">​<span class="figpopup-sensitive-area" style="left: -1.5em;">and2</span></span><span>2</span></a> and <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Tables S14 and S15</a>. None of the associations reported above were associated with placebo treatment.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC5828950/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139874152196576" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is nihms921427f2.jpg" title="An external file that holds a picture, illustration, etc.
Object name is nihms921427f2.jpg" src="/pmc/articles/PMC5828950/bin/nihms921427f2.jpg"></div></a><div id="largeobj_idm139874152196576" class="largeobj-link align_right" style="display: none"><a href="/pmc/articles/PMC5828950/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a target="object" href="/pmc/articles/PMC5828950/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC5828950/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p8">Manhattan plot of single-nucleotide polymorphism associations with change in low-density lipoprotein in white subjects only. [Color figure can be viewed at <a href="http://wileyonlinelibrary.com" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">wileyonlinelibrary.com</a>]</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p10">Lead SNPs associated with LDL in common variant analysis (<em>P</em> &lt; 1 × 10<sup>−6</sup>)</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139874152987264" class="xtable"><table frame="hsides" rules="rows" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="top" align="left">Race</th><th rowspan="1" colspan="1" valign="top" align="left">SNP</th><th rowspan="1" colspan="1" valign="top" align="right">Chromosome</th><th rowspan="1" colspan="1" valign="top" align="right">Position</th><th rowspan="1" colspan="1" valign="top" align="left">Gene</th><th rowspan="1" colspan="1" valign="top" align="left">Type</th><th rowspan="1" colspan="1" valign="top" align="left">MAF</th><th rowspan="1" colspan="1" valign="top" align="right">Beta</th><th rowspan="1" colspan="1" valign="top" align="center">Fibrate <em>P</em> value</th><th rowspan="1" colspan="1" valign="top" align="center">Placebo <em>P</em> value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">All races</td><td rowspan="1" colspan="1" valign="top" align="left">rs73354145</td><td rowspan="1" colspan="1" valign="top" align="right">17</td><td rowspan="1" colspan="1" valign="top" align="right">81706392</td><td rowspan="1" colspan="1" valign="top" align="left"><em>MRPL12</em></td><td rowspan="1" colspan="1" valign="top" align="left">IMPU</td><td rowspan="1" colspan="1" valign="top" align="left">0.037</td><td rowspan="1" colspan="1" valign="top" align="right">0.032</td><td rowspan="1" colspan="1" valign="top" align="center">2.39 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.699</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">All races</td><td rowspan="1" colspan="1" valign="top" align="left">rs2607653</td><td rowspan="1" colspan="1" valign="top" align="right">13</td><td rowspan="1" colspan="1" valign="top" align="right">102066313</td><td rowspan="1" colspan="1" valign="top" align="left"><em>FGF14</em></td><td rowspan="1" colspan="1" valign="top" align="left">IMPU</td><td rowspan="1" colspan="1" valign="top" align="left">0.031</td><td rowspan="1" colspan="1" valign="top" align="right">0.038</td><td rowspan="1" colspan="1" valign="top" align="center">4.28 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.262</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs72804453</td><td rowspan="1" colspan="1" valign="top" align="right">10</td><td rowspan="1" colspan="1" valign="top" align="right">58827231</td><td rowspan="1" colspan="1" valign="top" align="left"><em>BICC1</em></td><td rowspan="1" colspan="1" valign="top" align="left">IMPU</td><td rowspan="1" colspan="1" valign="top" align="left">0.043</td><td rowspan="1" colspan="1" valign="top" align="right">0.111</td><td rowspan="1" colspan="1" valign="top" align="center">3.74 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.950</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs112284299</td><td rowspan="1" colspan="1" valign="top" align="right">3</td><td rowspan="1" colspan="1" valign="top" align="right">179850307</td><td rowspan="1" colspan="1" valign="top" align="left"><em>PEX5L</em></td><td rowspan="1" colspan="1" valign="top" align="left">IMPU</td><td rowspan="1" colspan="1" valign="top" align="left">0.036</td><td rowspan="1" colspan="1" valign="top" align="right">0.107</td><td rowspan="1" colspan="1" valign="top" align="center">7.02 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.197</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs1653969</td><td rowspan="1" colspan="1" valign="top" align="right">3</td><td rowspan="1" colspan="1" valign="top" align="right">71282212</td><td rowspan="1" colspan="1" valign="top" align="left"><em>FOXP1</em></td><td rowspan="1" colspan="1" valign="top" align="left">IMPU</td><td rowspan="1" colspan="1" valign="top" align="left">0.492</td><td rowspan="1" colspan="1" valign="top" align="right">0.037</td><td rowspan="1" colspan="1" valign="top" align="center">9.18 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.232</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">White</td><td rowspan="1" colspan="1" valign="top" align="left">rs150268548<sup>a</sup></td><td rowspan="1" colspan="1" valign="top" align="right">19</td><td rowspan="1" colspan="1" valign="top" align="right">19383673</td><td rowspan="1" colspan="1" valign="top" align="left"><em>PBX4</em>, <em>MAU2</em></td><td rowspan="1" colspan="1" valign="top" align="left">IMPU</td><td rowspan="1" colspan="1" valign="top" align="left">0.075</td><td rowspan="1" colspan="1" valign="top" align="right">−0.028</td><td rowspan="1" colspan="1" valign="top" align="center">8.73 × 10<sup>−8</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.567</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">White</td><td rowspan="1" colspan="1" valign="top" align="left">rs9285630</td><td rowspan="1" colspan="1" valign="top" align="right">1</td><td rowspan="1" colspan="1" valign="top" align="right">98677990</td><td rowspan="1" colspan="1" valign="top" align="left"><em>SNX7</em></td><td rowspan="1" colspan="1" valign="top" align="left">IMPU</td><td rowspan="1" colspan="1" valign="top" align="left">0.173</td><td rowspan="1" colspan="1" valign="top" align="right">−0.022</td><td rowspan="1" colspan="1" valign="top" align="center">8.09 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.419</td></tr></tbody></table></div><div id="largeobj_idm139874152987264" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5828950/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN1"><p id="__p11" class="p p-first-last">MAF, minor allele frequency; SNP, single-nucleotide polymorphism.</p></div><div id="TFN2"><sup>a</sup>rs150268548 is not located in a gene, but SNPs in the same peak (<em>P</em> &lt; 1 × 10<sup>−6</sup>) are located in <em>PBX4</em> and <em>MAU2</em>.</div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p13">Lead SNPs associated with total cholesterol in common variant analysis (<em>P</em> &lt; 1 × 10<sup>−6</sup>)</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139874149603424" class="xtable"><table frame="hsides" rules="rows" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="top" align="left">Race</th><th rowspan="1" colspan="1" valign="top" align="left">SNP</th><th rowspan="1" colspan="1" valign="top" align="right">Chromosome</th><th rowspan="1" colspan="1" valign="top" align="right">Position</th><th rowspan="1" colspan="1" valign="top" align="left">Gene</th><th rowspan="1" colspan="1" valign="top" align="center">Type</th><th rowspan="1" colspan="1" valign="top" align="center">MAF</th><th rowspan="1" colspan="1" valign="top" align="center">Beta</th><th rowspan="1" colspan="1" valign="top" align="center">Fibrate <em>P</em> value</th><th rowspan="1" colspan="1" valign="top" align="center">Placebo <em>P</em> value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">All races</td><td rowspan="1" colspan="1" valign="top" align="left">rs6693796</td><td rowspan="1" colspan="1" valign="top" align="right">1</td><td rowspan="1" colspan="1" valign="top" align="right">170674136</td><td rowspan="1" colspan="1" valign="top" align="left"><em>PRRX1</em></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.044</td><td rowspan="1" colspan="1" valign="top" align="center">0.019</td><td rowspan="1" colspan="1" valign="top" align="center">6.23 × 10<sup>−8</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.040</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">All races</td><td rowspan="1" colspan="1" valign="top" align="left">rs2607653</td><td rowspan="1" colspan="1" valign="top" align="right">13</td><td rowspan="1" colspan="1" valign="top" align="right">102066313</td><td rowspan="1" colspan="1" valign="top" align="left"><em>FGF14</em></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.031</td><td rowspan="1" colspan="1" valign="top" align="center">0.023</td><td rowspan="1" colspan="1" valign="top" align="center">9.51 × 10<sup>−8</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.150</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">All races</td><td rowspan="1" colspan="1" valign="top" align="left">rs7810240</td><td rowspan="1" colspan="1" valign="top" align="right">7</td><td rowspan="1" colspan="1" valign="top" align="right">150387371</td><td rowspan="1" colspan="1" valign="top" align="left"><em>ZNF775</em></td><td rowspan="1" colspan="1" valign="top" align="center">META</td><td rowspan="1" colspan="1" valign="top" align="center">0.461</td><td rowspan="1" colspan="1" valign="top" align="center">−0.015</td><td rowspan="1" colspan="1" valign="top" align="center">1.99 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.711</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">All races</td><td rowspan="1" colspan="1" valign="top" align="left">rs73354145</td><td rowspan="1" colspan="1" valign="top" align="right">17</td><td rowspan="1" colspan="1" valign="top" align="right">81706392</td><td rowspan="1" colspan="1" valign="top" align="left"><em>MRPL12</em></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.037</td><td rowspan="1" colspan="1" valign="top" align="center">0.018</td><td rowspan="1" colspan="1" valign="top" align="center">2.66 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.801</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">All races</td><td rowspan="1" colspan="1" valign="top" align="left">rs80333777</td><td rowspan="1" colspan="1" valign="top" align="right">5</td><td rowspan="1" colspan="1" valign="top" align="right">15524360</td><td rowspan="1" colspan="1" valign="top" align="left"><em>FBXL7</em></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.032</td><td rowspan="1" colspan="1" valign="top" align="center">0.020</td><td rowspan="1" colspan="1" valign="top" align="center">4.76 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.021</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">All races</td><td rowspan="1" colspan="1" valign="top" align="left">rs9472719</td><td rowspan="1" colspan="1" valign="top" align="right">6</td><td rowspan="1" colspan="1" valign="top" align="right">46183648</td><td rowspan="1" colspan="1" valign="top" align="left"></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.264</td><td rowspan="1" colspan="1" valign="top" align="center">0.008</td><td rowspan="1" colspan="1" valign="top" align="center">8.98 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.553</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs72804453</td><td rowspan="1" colspan="1" valign="top" align="right">10</td><td rowspan="1" colspan="1" valign="top" align="right">58827231</td><td rowspan="1" colspan="1" valign="top" align="left"><em>BICC1</em></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.043</td><td rowspan="1" colspan="1" valign="top" align="center">0.078</td><td rowspan="1" colspan="1" valign="top" align="center">7.61 × 10<sup>−11</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.648</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs80147136</td><td rowspan="1" colspan="1" valign="top" align="right">16</td><td rowspan="1" colspan="1" valign="top" align="right">47050041</td><td rowspan="1" colspan="1" valign="top" align="left"></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.033</td><td rowspan="1" colspan="1" valign="top" align="center">0.071</td><td rowspan="1" colspan="1" valign="top" align="center">2.38 × 10<sup>−8</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.344</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs34030778</td><td rowspan="1" colspan="1" valign="top" align="right">8</td><td rowspan="1" colspan="1" valign="top" align="right">1771327</td><td rowspan="1" colspan="1" valign="top" align="left"><em>CLN8</em></td><td rowspan="1" colspan="1" valign="top" align="center">GENO</td><td rowspan="1" colspan="1" valign="top" align="center">0.047</td><td rowspan="1" colspan="1" valign="top" align="center">0.124</td><td rowspan="1" colspan="1" valign="top" align="center">4.10 × 10<sup>−8</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.374</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs181126208</td><td rowspan="1" colspan="1" valign="top" align="right">1</td><td rowspan="1" colspan="1" valign="top" align="right">236495209</td><td rowspan="1" colspan="1" valign="top" align="left"></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.051</td><td rowspan="1" colspan="1" valign="top" align="center">0.066</td><td rowspan="1" colspan="1" valign="top" align="center">6.88 × 10<sup>−8</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.016</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs112284299</td><td rowspan="1" colspan="1" valign="top" align="right">3</td><td rowspan="1" colspan="1" valign="top" align="right">179850307</td><td rowspan="1" colspan="1" valign="top" align="left"><em>PEX5L</em></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.036</td><td rowspan="1" colspan="1" valign="top" align="center">0.065</td><td rowspan="1" colspan="1" valign="top" align="center">1.09 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.544</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs250567</td><td rowspan="1" colspan="1" valign="top" align="right">16</td><td rowspan="1" colspan="1" valign="top" align="right">23383077</td><td rowspan="1" colspan="1" valign="top" align="left"></td><td rowspan="1" colspan="1" valign="top" align="center">META</td><td rowspan="1" colspan="1" valign="top" align="center">0.107</td><td rowspan="1" colspan="1" valign="top" align="center">0.072</td><td rowspan="1" colspan="1" valign="top" align="center">1.36 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.347</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs141864436</td><td rowspan="1" colspan="1" valign="top" align="right">2</td><td rowspan="1" colspan="1" valign="top" align="right">50971651</td><td rowspan="1" colspan="1" valign="top" align="left"><em>NRXN1</em></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.032</td><td rowspan="1" colspan="1" valign="top" align="center">0.062</td><td rowspan="1" colspan="1" valign="top" align="center">1.37 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.294</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs10034465</td><td rowspan="1" colspan="1" valign="top" align="right">4</td><td rowspan="1" colspan="1" valign="top" align="right">34193881</td><td rowspan="1" colspan="1" valign="top" align="left"><em>LOC105374394</em></td><td rowspan="1" colspan="1" valign="top" align="center">META</td><td rowspan="1" colspan="1" valign="top" align="center">0.357</td><td rowspan="1" colspan="1" valign="top" align="center">0.053</td><td rowspan="1" colspan="1" valign="top" align="center">1.47 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.711</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs113816795</td><td rowspan="1" colspan="1" valign="top" align="right">5</td><td rowspan="1" colspan="1" valign="top" align="right">99159793</td><td rowspan="1" colspan="1" valign="top" align="left"></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.032</td><td rowspan="1" colspan="1" valign="top" align="center">0.072</td><td rowspan="1" colspan="1" valign="top" align="center">1.71 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.487</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs112209655</td><td rowspan="1" colspan="1" valign="top" align="right">12</td><td rowspan="1" colspan="1" valign="top" align="right">84947357</td><td rowspan="1" colspan="1" valign="top" align="left"><em>LOC102724680</em></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.040</td><td rowspan="1" colspan="1" valign="top" align="center">0.066</td><td rowspan="1" colspan="1" valign="top" align="center">1.89 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.008</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs117168171</td><td rowspan="1" colspan="1" valign="top" align="right">15</td><td rowspan="1" colspan="1" valign="top" align="right">101854598</td><td rowspan="1" colspan="1" valign="top" align="left"></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.033</td><td rowspan="1" colspan="1" valign="top" align="center">0.066</td><td rowspan="1" colspan="1" valign="top" align="center">2.43 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.615</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs2823310</td><td rowspan="1" colspan="1" valign="top" align="right">21</td><td rowspan="1" colspan="1" valign="top" align="right">15497528</td><td rowspan="1" colspan="1" valign="top" align="left"></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.092</td><td rowspan="1" colspan="1" valign="top" align="center">0.043</td><td rowspan="1" colspan="1" valign="top" align="center">2.72 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.664</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs143838781</td><td rowspan="1" colspan="1" valign="top" align="right">12</td><td rowspan="1" colspan="1" valign="top" align="right">113940538</td><td rowspan="1" colspan="1" valign="top" align="left"><em>RBM19</em></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.035</td><td rowspan="1" colspan="1" valign="top" align="center">0.061</td><td rowspan="1" colspan="1" valign="top" align="center">3.56 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.571</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs75298135</td><td rowspan="1" colspan="1" valign="top" align="right">5</td><td rowspan="1" colspan="1" valign="top" align="right">28184371</td><td rowspan="1" colspan="1" valign="top" align="left"></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.030</td><td rowspan="1" colspan="1" valign="top" align="center">0.065</td><td rowspan="1" colspan="1" valign="top" align="center">3.74 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.899</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs75639901</td><td rowspan="1" colspan="1" valign="top" align="right">6</td><td rowspan="1" colspan="1" valign="top" align="right">25667802</td><td rowspan="1" colspan="1" valign="top" align="left"><em>SCGN</em></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.077</td><td rowspan="1" colspan="1" valign="top" align="center">0.039</td><td rowspan="1" colspan="1" valign="top" align="center">5.08 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.617</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs115990514</td><td rowspan="1" colspan="1" valign="top" align="right">3</td><td rowspan="1" colspan="1" valign="top" align="right">19055897</td><td rowspan="1" colspan="1" valign="top" align="left"></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.033</td><td rowspan="1" colspan="1" valign="top" align="center">0.065</td><td rowspan="1" colspan="1" valign="top" align="center">5.43 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.118</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs138270994</td><td rowspan="1" colspan="1" valign="top" align="right">13</td><td rowspan="1" colspan="1" valign="top" align="right">22791996</td><td rowspan="1" colspan="1" valign="top" align="left"></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.055</td><td rowspan="1" colspan="1" valign="top" align="center">0.045</td><td rowspan="1" colspan="1" valign="top" align="center">6.23 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.387</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs76043556</td><td rowspan="1" colspan="1" valign="top" align="right">15</td><td rowspan="1" colspan="1" valign="top" align="right">30060225</td><td rowspan="1" colspan="1" valign="top" align="left"></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.044</td><td rowspan="1" colspan="1" valign="top" align="center">0.058</td><td rowspan="1" colspan="1" valign="top" align="center">6.66 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.156</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs58847779</td><td rowspan="1" colspan="1" valign="top" align="right">22</td><td rowspan="1" colspan="1" valign="top" align="right">37736643</td><td rowspan="1" colspan="1" valign="top" align="left"><em>TRIOBP</em></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.077</td><td rowspan="1" colspan="1" valign="top" align="center">0.039</td><td rowspan="1" colspan="1" valign="top" align="center">6.77 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.503</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs62210650</td><td rowspan="1" colspan="1" valign="top" align="right">21</td><td rowspan="1" colspan="1" valign="top" align="right">19649853</td><td rowspan="1" colspan="1" valign="top" align="left"><em>LOC105372744</em></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.034</td><td rowspan="1" colspan="1" valign="top" align="center">0.064</td><td rowspan="1" colspan="1" valign="top" align="center">6.82 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.200</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs146807753</td><td rowspan="1" colspan="1" valign="top" align="right">6</td><td rowspan="1" colspan="1" valign="top" align="right">3904004</td><td rowspan="1" colspan="1" valign="top" align="left"></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.030</td><td rowspan="1" colspan="1" valign="top" align="center">0.060</td><td rowspan="1" colspan="1" valign="top" align="center">7.37 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.380</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs116616455</td><td rowspan="1" colspan="1" valign="top" align="right">12</td><td rowspan="1" colspan="1" valign="top" align="right">58041828</td><td rowspan="1" colspan="1" valign="top" align="left"></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.065</td><td rowspan="1" colspan="1" valign="top" align="center">0.047</td><td rowspan="1" colspan="1" valign="top" align="center">7.47 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.000</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs114007472</td><td rowspan="1" colspan="1" valign="top" align="right">8</td><td rowspan="1" colspan="1" valign="top" align="right">63563680</td><td rowspan="1" colspan="1" valign="top" align="left"></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.036</td><td rowspan="1" colspan="1" valign="top" align="center">0.071</td><td rowspan="1" colspan="1" valign="top" align="center">7.51 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.840</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs145010525</td><td rowspan="1" colspan="1" valign="top" align="right">2</td><td rowspan="1" colspan="1" valign="top" align="right">135975205</td><td rowspan="1" colspan="1" valign="top" align="left"><em>DARS</em></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.033</td><td rowspan="1" colspan="1" valign="top" align="center">0.058</td><td rowspan="1" colspan="1" valign="top" align="center">8.20 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.968</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs4988198</td><td rowspan="1" colspan="1" valign="top" align="right">2</td><td rowspan="1" colspan="1" valign="top" align="right">0.0076</td><td rowspan="1" colspan="1" valign="top" align="left"><em>MCM6</em></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.033</td><td rowspan="1" colspan="1" valign="top" align="center">0.058</td><td rowspan="1" colspan="1" valign="top" align="center">8.74 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.964</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs6847878</td><td rowspan="1" colspan="1" valign="top" align="right">4</td><td rowspan="1" colspan="1" valign="top" align="right">81419697</td><td rowspan="1" colspan="1" valign="top" align="left"></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.032</td><td rowspan="1" colspan="1" valign="top" align="center">0.062</td><td rowspan="1" colspan="1" valign="top" align="center">9.57 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.333</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs2631781</td><td rowspan="1" colspan="1" valign="top" align="right">1</td><td rowspan="1" colspan="1" valign="top" align="right">76128100</td><td rowspan="1" colspan="1" valign="top" align="left"><em>ST6GALNAC3</em></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.041</td><td rowspan="1" colspan="1" valign="top" align="center">0.051</td><td rowspan="1" colspan="1" valign="top" align="center">9.66 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.181</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Black</td><td rowspan="1" colspan="1" valign="top" align="left">rs115092681</td><td rowspan="1" colspan="1" valign="top" align="right">3</td><td rowspan="1" colspan="1" valign="top" align="right">174201322</td><td rowspan="1" colspan="1" valign="top" align="left"><em>NLGN1</em></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.033</td><td rowspan="1" colspan="1" valign="top" align="center">0.061</td><td rowspan="1" colspan="1" valign="top" align="center">9.82 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.424</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">White</td><td rowspan="1" colspan="1" valign="top" align="left">rs57504626</td><td rowspan="1" colspan="1" valign="top" align="right">19</td><td rowspan="1" colspan="1" valign="top" align="right">19609589</td><td rowspan="1" colspan="1" valign="top" align="left"><em>PBX4</em></td><td rowspan="1" colspan="1" valign="top" align="center">IMPU</td><td rowspan="1" colspan="1" valign="top" align="center">0.092</td><td rowspan="1" colspan="1" valign="top" align="center">−0.014</td><td rowspan="1" colspan="1" valign="top" align="center">6.22 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.641</td></tr></tbody></table></div><div id="largeobj_idm139874149603424" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC5828950/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN3"><p id="__p14" class="p p-first-last">MAF, minor allele frequency; SNP, single-nucleotide polymorphism.</p></div></div></div></div><div id="S3" class="sec"><h3 id="S3title">Rare variant analysis</h3><p id="P9" class="p p-first-last">A total of 17,081 genes were tested for association with TG, TC, HDL, or LDL in all races combined, white subjects only and black subjects only with rare variants (MAF ≤0.03). When all races were combined, <em>DCUN1D4</em> and <em>DUSP3</em> were significantly associated (<em>q</em> &lt; 0.2) with TG. Additionally, when only white subjects were included, <em>HARS2</em> was significantly associated with TG and HDL, <em>HSD17B13</em> was significantly associated with TG and HDL, <em>AKR7A3</em> was significantly associated with LDL and TC, and <em>MARCH3</em> was significantly associated with TG (<em>q</em> &lt; 0.2). Last, POGZ was significantly associated with TG in black subjects only (<em>q</em> &lt; 0.2; <a href="/pmc/articles/PMC5828950/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>). None of the genes reported above were associated with subjects treated with placebo (<em>q</em> = 1; <a href="/pmc/articles/PMC5828950/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p id="__p15">Results from rare variant analysis (<em>q</em> &lt; 0.2)</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139874146266928" class="xtable"><table frame="hsides" rules="rows" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="top" align="left">Phenotype</th><th rowspan="1" colspan="1" valign="top" align="center">Race</th><th rowspan="1" colspan="1" valign="top" align="left">Gene</th><th rowspan="1" colspan="1" valign="top" align="center">Fibrate Lancaster <em>P</em> value</th><th rowspan="1" colspan="1" valign="top" align="center">Fibrate <em>q</em> value</th><th rowspan="1" colspan="1" valign="top" align="center">Placebo Lancaster <em>p</em> value</th><th rowspan="1" colspan="1" valign="top" align="center">Placebo <em>q</em> value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">TG</td><td rowspan="1" colspan="1" valign="top" align="center">Black</td><td rowspan="1" colspan="1" valign="top" align="left"><em>POGZ</em></td><td rowspan="1" colspan="1" valign="top" align="center">1.00 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.017</td><td rowspan="1" colspan="1" valign="top" align="center">0.113</td><td rowspan="1" colspan="1" valign="top" align="center">1</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">HDL</td><td rowspan="1" colspan="1" valign="top" align="center">White</td><td rowspan="1" colspan="1" valign="top" align="left"><em>HSD17B13</em></td><td rowspan="1" colspan="1" valign="top" align="center">2.15 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.037</td><td rowspan="1" colspan="1" valign="top" align="center">0.445</td><td rowspan="1" colspan="1" valign="top" align="center">1</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">TG</td><td rowspan="1" colspan="1" valign="top" align="center">White</td><td rowspan="1" colspan="1" valign="top" align="left"><em>HARS2</em></td><td rowspan="1" colspan="1" valign="top" align="center">3.09 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.053</td><td rowspan="1" colspan="1" valign="top" align="center">0.726</td><td rowspan="1" colspan="1" valign="top" align="center">1</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">TG</td><td rowspan="1" colspan="1" valign="top" align="center">White</td><td rowspan="1" colspan="1" valign="top" align="left"><em>HSD17B13</em></td><td rowspan="1" colspan="1" valign="top" align="center">4.42 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.075</td><td rowspan="1" colspan="1" valign="top" align="center">0.534</td><td rowspan="1" colspan="1" valign="top" align="center">1</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">LDL</td><td rowspan="1" colspan="1" valign="top" align="center">White</td><td rowspan="1" colspan="1" valign="top" align="left"><em>AKR7A3</em></td><td rowspan="1" colspan="1" valign="top" align="center">4.80 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.082</td><td rowspan="1" colspan="1" valign="top" align="center">0.271</td><td rowspan="1" colspan="1" valign="top" align="center">1</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">HDL</td><td rowspan="1" colspan="1" valign="top" align="center">White</td><td rowspan="1" colspan="1" valign="top" align="left"><em>HARS2</em></td><td rowspan="1" colspan="1" valign="top" align="center">7.09 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.121</td><td rowspan="1" colspan="1" valign="top" align="center">0.327</td><td rowspan="1" colspan="1" valign="top" align="center">1</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">TG</td><td rowspan="1" colspan="1" valign="top" align="center">All races</td><td rowspan="1" colspan="1" valign="top" align="left"><em>DCUN1D4</em></td><td rowspan="1" colspan="1" valign="top" align="center">7.46 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.127</td><td rowspan="1" colspan="1" valign="top" align="center">0.322</td><td rowspan="1" colspan="1" valign="top" align="center">1</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">TG</td><td rowspan="1" colspan="1" valign="top" align="center">All races</td><td rowspan="1" colspan="1" valign="top" align="left"><em>DUSP3</em></td><td rowspan="1" colspan="1" valign="top" align="center">9.20 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.157</td><td rowspan="1" colspan="1" valign="top" align="center">0.142</td><td rowspan="1" colspan="1" valign="top" align="center">1</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">TG</td><td rowspan="1" colspan="1" valign="top" align="center">White</td><td rowspan="1" colspan="1" valign="top" align="left"><em>MARCH3</em></td><td rowspan="1" colspan="1" valign="top" align="center">9.80 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.167</td><td rowspan="1" colspan="1" valign="top" align="center">0.040</td><td rowspan="1" colspan="1" valign="top" align="center">1</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">TC</td><td rowspan="1" colspan="1" valign="top" align="center">White</td><td rowspan="1" colspan="1" valign="top" align="left"><em>AKR7A3</em></td><td rowspan="1" colspan="1" valign="top" align="center">1.17 × 10<sup>−5</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.199</td><td rowspan="1" colspan="1" valign="top" align="center">0.241</td><td rowspan="1" colspan="1" valign="top" align="center">1</td></tr></tbody></table></div><div id="largeobj_idm139874146266928" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5828950/table/T3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN4"><p id="__p16" class="p p-first-last">HDL, high-density lipoprotein; LDL, low-density lipoprotein; TC, total cholesterol; TG, triglyceride.</p></div></div></div></div><div id="S4" class="sec sec-last"><h3 id="S4title">Functional validation</h3><p id="P10" class="p p-first-last">SNPs in genes in the common variant analysis with <em>P</em> &lt; 1 × 10<sup>−5</sup> or <em>q</em> &lt; 0.2 in the rare variant analysis were compared to gene expression results in wild-type C57BL/6J mice fed vehicle control or fenofibrate for replication<sup><a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881226">20</a></sup> (REP1). Fifty-seven genes overlapped between the two studies, and 10 were significant in REP1 (<em>q</em> &lt; 0.3; <em>Mcm6</em>, <em>Smad3</em>, <em>Dcun1d4</em>, <em>Hecw2</em>, <em>Mipep</em>, <em>Ipo11</em>, <em>R3hdm1</em>, <em>Foxp1</em>, <em>Stx8</em>, and <em>Mapk10</em>; <a href="/pmc/articles/PMC5828950/table/T4/" target="table" class="fig-table-link figpopup" rid-figpopup="T4" rid-ob="ob-T4" co-legend-rid=""><span>Table 4</span></a>). These genes and 3 additional genes that met our threshold for inclusion in the replication study but were not available in the previously published REP1 study (<em>Hsd17b13</em>, <em>Pbx4</em>, and <em>Cyp4f39</em>) were subsequently tested in REP2, a follow-up gene expression study in mice to confirm the changes in response to fenofibrate vs. vehicle control in liver, adipose, and skeletal muscle. <em>Cyp4f39</em> was tested in REP2 because it is the murine homologue of <em>CYP4F22</em> in humans, which was marginally significant for change in HDL in ACCORD (<em>P</em> &lt; 1 × 10<sup>−5</sup>). All genes, except <em>Mipep</em> and <em>Cyp4f39</em>, were significantly changed in liver tissue in REP2 (<em>q</em> &lt; 0.3), however, the direction of the effect was not always consistent with REP1 (<a href="/pmc/articles/PMC5828950/table/T4/" target="table" class="fig-table-link figpopup" rid-figpopup="T4" rid-ob="ob-T4" co-legend-rid=""><span>Table 4</span></a>). Genes <em>Smad3</em>, <em>Ipo11</em>, <em>and Foxp1</em> were significantly decreased in both REP1 and REP2 and were considered to have successfully replicated the GWAS findings. <em>Hsd17b13</em> and <em>Pbx4</em> were significantly decreased in liver tissue in REP2 (<em>q</em> &lt; 0.3; <a href="/pmc/articles/PMC5828950/table/T4/" target="table" class="fig-table-link figpopup" rid-figpopup="T4" rid-ob="ob-T4" co-legend-rid=""><span>Table 4</span></a>). REP1 was published previously and did not include <em>Hsd17b13</em> or <em>Pbx4</em>, so these genes were not available for replication in REP1. However, both of these genes were tested in REP2. There were no significant results for gene expression tested in adipose or skeletal muscle (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table S16</a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T4"><h3>Table 4</h3><!--caption a7--><div class="caption"><p id="__p17">Replication of ACCORD common and rare variant results in REP1 and REP2 replication sets</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139874184880880" class="xtable"><table frame="hsides" rules="rows" class="rendered small default_table"><thead><tr><th rowspan="2" colspan="1" valign="bottom" align="left">Gene symbol</th><th rowspan="2" colspan="1" valign="bottom" align="left">Gene name</th><th colspan="3" rowspan="1" valign="bottom" align="center">REP1</th><th colspan="2" rowspan="1" valign="bottom" align="center">REP2</th><th rowspan="2" colspan="1" valign="bottom" align="center">Replication concordance</th></tr><tr><th rowspan="1" colspan="1" valign="bottom" align="center">Fold change</th><th rowspan="1" colspan="1" valign="bottom" align="center"><em>P</em> value</th><th rowspan="1" colspan="1" valign="bottom" align="center">FDR <em>P</em> value</th><th rowspan="1" colspan="1" valign="bottom" align="center">Liver fold change</th><th rowspan="1" colspan="1" valign="bottom" align="center">Liver FDR <em>P</em> value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left"><em>Mcm6</em></td><td rowspan="1" colspan="1" valign="top" align="left">Minichromosome maintenance complex component 6</td><td rowspan="1" colspan="1" valign="top" align="center">1.69</td><td rowspan="1" colspan="1" valign="top" align="center">5.35 × 10<sup>−4</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.034</td><td rowspan="1" colspan="1" valign="top" align="center">−0.351</td><td rowspan="1" colspan="1" valign="top" align="center">0.298</td><td rowspan="1" colspan="1" valign="top" align="center">⇅</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"><em>Smad3</em></td><td rowspan="1" colspan="1" valign="top" align="left">SMAD family member 3</td><td rowspan="1" colspan="1" valign="top" align="center">−2.23</td><td rowspan="1" colspan="1" valign="top" align="center">2.88 × 10<sup>−3</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.091</td><td rowspan="1" colspan="1" valign="top" align="center">−0.625</td><td rowspan="1" colspan="1" valign="top" align="center">0.192</td><td rowspan="1" colspan="1" valign="top" align="center">⇊</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"><em>Dcun1d4</em></td><td rowspan="1" colspan="1" valign="top" align="left">Defective in cullin neddylation 1 domain containing 4</td><td rowspan="1" colspan="1" valign="top" align="center">1.47</td><td rowspan="1" colspan="1" valign="top" align="center">0.013</td><td rowspan="1" colspan="1" valign="top" align="center">0.194</td><td rowspan="1" colspan="1" valign="top" align="center">−0.563</td><td rowspan="1" colspan="1" valign="top" align="center">0.065</td><td rowspan="1" colspan="1" valign="top" align="center">⇅</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"><em>Hecw2</em></td><td rowspan="1" colspan="1" valign="top" align="left">HECT, C2, and WW domain containing E3 ubiquitin protein ligase 2</td><td rowspan="1" colspan="1" valign="top" align="center">2.31</td><td rowspan="1" colspan="1" valign="top" align="center">0.014</td><td rowspan="1" colspan="1" valign="top" align="center">0.194</td><td rowspan="1" colspan="1" valign="top" align="center">−0.563</td><td rowspan="1" colspan="1" valign="top" align="center">0.098</td><td rowspan="1" colspan="1" valign="top" align="center">⇅</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"><em>Mipep</em></td><td rowspan="1" colspan="1" valign="top" align="left">Mitochondrial intermediate peptidase</td><td rowspan="1" colspan="1" valign="top" align="center">1.72</td><td rowspan="1" colspan="1" valign="top" align="center">0.015</td><td rowspan="1" colspan="1" valign="top" align="center">0.194</td><td rowspan="1" colspan="1" valign="top" align="center">0.055</td><td rowspan="1" colspan="1" valign="top" align="center">0.791</td><td rowspan="1" colspan="1" valign="top" align="center">↑−</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"><em>Ipo11</em></td><td rowspan="1" colspan="1" valign="top" align="left">IMP 11</td><td rowspan="1" colspan="1" valign="top" align="center">−1.88</td><td rowspan="1" colspan="1" valign="top" align="center">0.022</td><td rowspan="1" colspan="1" valign="top" align="center">0.235</td><td rowspan="1" colspan="1" valign="top" align="center">−0.305</td><td rowspan="1" colspan="1" valign="top" align="center">0.147</td><td rowspan="1" colspan="1" valign="top" align="center">⇊</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"><em>R3hdm1</em></td><td rowspan="1" colspan="1" valign="top" align="left">R3H domain containing 1</td><td rowspan="1" colspan="1" valign="top" align="center">1.51</td><td rowspan="1" colspan="1" valign="top" align="center">0.030</td><td rowspan="1" colspan="1" valign="top" align="center">0.270</td><td rowspan="1" colspan="1" valign="top" align="center">−0.436</td><td rowspan="1" colspan="1" valign="top" align="center">0.065</td><td rowspan="1" colspan="1" valign="top" align="center">⇅</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"><em>Foxp1</em></td><td rowspan="1" colspan="1" valign="top" align="left">Forkhead box P1</td><td rowspan="1" colspan="1" valign="top" align="center">−1.41</td><td rowspan="1" colspan="1" valign="top" align="center">0.035</td><td rowspan="1" colspan="1" valign="top" align="center">0.276</td><td rowspan="1" colspan="1" valign="top" align="center">−0.624</td><td rowspan="1" colspan="1" valign="top" align="center">0.065</td><td rowspan="1" colspan="1" valign="top" align="center">⇊</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"><em>Stx8</em></td><td rowspan="1" colspan="1" valign="top" align="left">Syntaxin 8</td><td rowspan="1" colspan="1" valign="top" align="center">1.51</td><td rowspan="1" colspan="1" valign="top" align="center">0.043</td><td rowspan="1" colspan="1" valign="top" align="center">0.295</td><td rowspan="1" colspan="1" valign="top" align="center">−0.374</td><td rowspan="1" colspan="1" valign="top" align="center">0.065</td><td rowspan="1" colspan="1" valign="top" align="center">⇅</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"><em>Mapk10</em></td><td rowspan="1" colspan="1" valign="top" align="left">Mitogen-activated protein kinase 10</td><td rowspan="1" colspan="1" valign="top" align="center">−1.43</td><td rowspan="1" colspan="1" valign="top" align="center">0.047</td><td rowspan="1" colspan="1" valign="top" align="center">0.295</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">↓</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"><em>Hsd17b13</em></td><td rowspan="1" colspan="1" valign="top" align="left">Hydroxysteroid 17-β dehydrogenase 13</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">−0.526</td><td rowspan="1" colspan="1" valign="top" align="center">5.93 × 10<sup>−4</sup></td><td rowspan="1" colspan="1" valign="top" align="center">↓</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"><em>Pbx4</em></td><td rowspan="1" colspan="1" valign="top" align="left">PBX homeobox 4</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">−0.646</td><td rowspan="1" colspan="1" valign="top" align="center">0.122</td><td rowspan="1" colspan="1" valign="top" align="center">↓</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"><em>Cyp4f39</em><sup>a</sup></td><td rowspan="1" colspan="1" valign="top" align="left">Cytochrome P450, family 4, subfamily f, polypeptide 39</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">−0.237</td><td rowspan="1" colspan="1" valign="top" align="center">0.539</td><td rowspan="1" colspan="1" valign="top" align="center">–</td></tr></tbody></table></div><div id="largeobj_idm139874184880880" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC5828950/table/T4/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN5"><p id="__p18" class="p p-first-last">FDR, false discovery rate; IMP-11, importin 11; NA, not applicable.</p></div><div id="TFN6"><sup>a</sup><em>Cyp4f39</em> is the murine homologue for human <em>CYP4F22</em>; ↑ statistically significant increase (FDR <em>P</em> value &lt; 0.3); ↓ statistically significant decrease (FDR <em>P</em> value &lt; 0.3), fold change not statistically significant (FDR <em>P</em> value ≥0).</div></div></div></div></div><div id="S5" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S5title">DISCUSSION</h2><p id="P11" class="p p-first">Dyslipidemia continues to be a widespread disorder with significant health impacts worldwide. Although recent studies, including ACCORD, have raised questions concerning the role of additional lipid-lowering therapy in the context of statin to reduce cardiovascular events,<sup><a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881196">9</a>,<a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881201">21</a></sup> dyslipidemia remains a significant risk factor for CVD and fibrates are commonly prescribed.<sup><a href="#R22" rid="R22" class=" bibr popnode">22</a></sup> In addition, it is important to understand the variation in response to fenofibrate in people with T2D who are at an especially high risk of developing an adverse cardiovascular event (e.g., stroke and myocardial infarction). We previously published a meta-analysis combining the results of the fenofibrate lipid response in the GOLDN cohort with white subjects in ACCORD, and found significant associations with SNPs in <em>PBX4</em> and change in LDL in response to fenofibrate treatment.<sup><a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881195">14</a></sup> Here, we expand the previous study to include all races in ACCORD and black subjects only. In addition, we conduct a rare variant analysis for changes in HDL, LDL, TC, and TG and follow-up both common and rare variant GWAS findings in two studies of mice exposed to fenofibrate. Importantly, these functional validation studies highlight novel common and rare variants that contribute to variation in fenofibrate lipid response in individuals with T2D.</p><p id="P12">Combining all subjects that met our inclusion criteria in ACCORD resulted in 1,264 subjects available for analysis. Cytochrome P450 family 4 subfamily F member 22 (CYP4F22), was marginally associated with changes in HDL (<em>P</em> = 2.50 × 10<sup>−6</sup>, β = −0.023). CYP4F22 is part of the 12(R)-lipoxygenase pathway, and has been shown to produce potent PPARα agonists,<sup><a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881198">23</a>,<a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881215">24</a></sup> which makes SNPs in <em>CYP4F22</em> biologically plausible for causing variation in HDL, because PPARα is the therapeutic target of fenofibrate. Although the biological role of <em>CYP4F22</em> is a compelling candidate for fibrate drug response, <em>Cyp4f39</em>, the murine homologue of <em>CYP4F22</em>, did not replicate in REP2, suggesting that the GWAS finding may be a false-positive, the replication may have failed due to species differences or gene expression may not be the appropriate test for <em>CYP4F22</em> response to fenofibrate exposure.</p><p id="P13">In black subjects only, lead SNP rs142923802, located in importin 11 (<em>IPO11</em>) was also marginally associated with change in LDL (<em>P</em> = 1.52 × 10<sup>−6</sup>, β = 0.095). Gene expression of <em>Ipo11</em> was significantly decreased in both REP1 (<em>q</em> = 0.24) and in the liver in REP2 (<em>q</em> = 0.15). <em>IPO11</em> codes the nuclear import receptor, importin 11, and in conjunction with ubiquitin-conjugating enzyme, UBE2E3, restricts KEAP1, which is a major suppressor of Nrf2.<sup><a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881211">25</a></sup> Notably, Nrf2 in mice has been shown to interact with lipogenic genes and to regulate hepatic lipid homeostasis.<sup><a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881221">26</a></sup> Moreover, Nrf2-<em>null</em> mice displayed reduced liver weight, decreased fatty acid content of hepatic triacylglycerol, and increases in serum HDL, and very low-density lipoprotein triglyceride. Finally, PPARγ and other genes were found to be direct targets of Nrf2 activation, demonstrating that Nrf2, regulated by KEAP1 and IPO11 in humans, modulate lipid homeostasis. Rare variants in Aldo-keto reductase 7A3, <em>AKR7A3</em>, were significantly associated with LDL in white subjects only (<em>q</em> = 0.08). The AKR family of enzymes catalyze a wide range of endogenous and exogenous chemicals, including glucose, steroid hormones, and lipids. <em>Akr7a3</em> is transcriptionally regulated by Nrf2 in mice, which, in addition to IPO11 results discussed above, further supports the implication of Nrf2 signaling in regulating fenofibrate drug response.<sup><a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881191">27</a>,<a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881240">28</a></sup> Previous studies have demonstrated that Nrf2 signaling is activated by fenofibrate through <em>Keap1</em> in mice, and may be responsible for the protective effect of fenofibrate for oxidative stress.<sup><a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881193">29</a></sup> Here, we present evidence that SNPs located in genes in the Nrf2 signaling pathway may play an important role in regulating the change in LDL upon fenofibrate treatment.</p><p id="P14">In black subjects, rs12912310, located in the gene, mothers against decapentaplegic-3 (<em>SMAD3</em>), was marginally associated with LDL (<em>P</em> = 5.75 × 10<sup>−6</sup>) and TC (<em>P</em> = 1.88 × 10<sup>−6</sup>). <em>Smad3</em> expression was significantly decreased in response to fenofibrate in both REP1 (<em>q</em> = 0.09) and REP2 (<em>q</em> = 0.19). SMAD3 is a member of the SMAD family of genes and is an intracellular signal transducer and transcriptional modulator activated by transforming growth factor-beta (TGF-β), and binds to the promoter region of many genes regulated by TGF-β and activates them by forming a SMAD3/SMAD4 complex.<sup><a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881238">30</a>–<a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881212">32</a></sup> In a study by Tan <em>et al</em>.,<sup><a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881239">31</a></sup> SMAD3 knockout mice had lower plasma free fatty acid and glycerol, and reduced adiposity. The same study demonstrated that SMAD3 knockout mice had altered regulation of PPARγ and PPARβ. Furthermore, PPARα, the therapeutic target of fenofibrate, has been shown to inhibit TGF-β, which regulates SMAD2, SMAD3, and SMAD4 transcription factors.<sup><a href="#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881194">33</a></sup> Pathways involving PPARα, TGF-β, and SMAD transcription factors are clearly convoluted and more research is needed to elucidate these relationships, and these results suggest that <em>SMAD3</em> may play a role in fenofibrate lipid response. Furthermore, in black subjects, SNP rs1653969 located in <em>FOXP1</em>, was associated with a poorer LDL response to fenofibrate (<em>P</em> = 9.18 × 10<sup>−7</sup>). <em>FOXP1</em> is a member of the forkhead box class of genes, which is a large family of transcription factors. Little is known about the role of FOXP1, but other FOX transcription factors (e.g., FOXO3a) have been shown to be impacted by fenofibrate treatment.<sup><a href="#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881205">34</a></sup> Importantly, expression of <em>Foxp1</em> was significantly decreased in both REP1 and REP2 analysis, and additional research is needed to further elucidate the role of <em>FOXP1</em> in fenofibrate lipid response.</p><p id="P15">When the cohort was limited to white subjects only, there was a significant association between LDL and the lead SNP, rs140229040, which is located in the PBX homeobox 4 (<em>PBX4</em>) gene (<em>P</em> = 3.66 × 10<sup>−7</sup>). SNPs in this gene are part of a large region in linkage disequilibrium, and this region has been previously identified as being associated with LDL cholesterol.<sup><a href="#R35" rid="R35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881202">35</a>–<a href="#R37" rid="R37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881235">37</a></sup> We reported this finding previously with a meta-analysis using the GOLDN cohort.<sup><a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881204">12</a></sup> This gene was not available for follow-up in REP1 but was significantly decreased in liver tissue of mice exposed to fenofibrate in REP2 (<em>q</em> = 0.12). Interestingly, functional validation in the study by Holmen <em>et al</em>.<sup><a href="#R38" rid="R38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881228">38</a></sup> identified TM6SF2, which is in high linkage disequilibrium with <em>PBX4</em>, as being the gene functionally responsible for regulating LDL.</p><p id="P16">We also tested rare variants for associations with LDL, HDL, TG, and TC. Six unique genes (<em>POGZ</em>, <em>HSD17B13</em>, <em>HARS2</em>, <em>DCUN1D4</em>, <em>DUSP3</em>, and <em>MARCH3</em>) were significantly associated with TG. Gene expression changes for <em>DCUN1D4</em> was significantly altered in both REP1 and REP2, but with opposing directions (<em>q</em> &lt; 0.3). Very little is known about the function of <em>DCUN1D4</em>, with studies mostly conducted in <em>C. elegans</em> and <em>S. cerevisiae</em>.<sup><a href="#R39" rid="R39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881233">39</a></sup> In addition to TG, <em>HSD17B13</em> was also associated with change in HDL in white subjects only (<em>q</em> &lt; 0.2). Importantly, rare genetic variants in hydroxysteroid 17-beta dehydrogenase 3 (<em>HSD17B13</em>) were significantly associated with TG and HDL in white subjects (<em>q</em> &lt; 0.05) and mice fed fenofibrate displayed a significant reduction in <em>Hsd17b13</em> gene expression when administered fenofibrate vs. vehicle control in REP2 (<em>q</em> = 5.93 × 10<sup>−4</sup>; <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table S6</a>). <em>HSD17B13</em>, an isoform of 17 beta-hydroxysteroid dehydrogenase (17βHSD), is highly expressed in the testis, and is also expressed in the liver.<sup><a href="#R40" rid="R40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881210">40</a></sup> However, other isoforms of 17βHSD are expressed in many tissues. Unlike many of the other isoforms of 17βHSD, only recently has the role of 17βHSD13 become clear. Human fatty liver samples have shown that 17βHSD13 is upregulated in lipid droplet fractions.<sup><a href="#R41" rid="R41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881189">41</a></sup> Furthermore, 17βHSD13 was significantly upregulated in the livers of both diabetic mice and mice fed high-fat diets, suggesting that 17βHSD13 may play an important role in the pathogenesis of fatty liver in both mice and in humans and may also be relevant in diabetes. In the same study, overexpression of <em>Hsd17b13</em> in C57BL/6 mouse livers increased lipogenesis and lipid accumulation and overexpression of <em>17βHSD13</em> increased lipid droplet formation in human cell lines.<sup><a href="#R41" rid="R41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881197">41</a></sup> Interestingly, in the mouse model, overexpression of <em>Hsd17b13</em> did not increase plasma TG or TC levels.<sup><a href="#R41" rid="R41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881199">41</a></sup> Although the results presented by Su <em>et al</em>.<sup><a href="#R41" rid="R41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881207">41</a></sup> demonstrate a clear role of 17βHSD13 in nonalcoholic fatty liver disease, the results presented here mark the first time that rare variant SNPs in 17βHSD13 have been shown to impact the lipid lowering effects of fenofibrate.<sup><a href="#R41" rid="R41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881190">41</a></sup> Additional research is needed to fully elucidate the relationship between 17βHSD13 and fenofibrate lipid response. It is possible that <em>17βHSD13</em> may become an important biomarker in precision medicine initiatives for more targeted treatment of fenofibrate.</p><p id="P17">These findings occurred in subjects with T2D treated with statins, which is more clinically representative than fenofibrate monotherapy, because fibrates are commonly prescribed with statin therapy.<sup><a href="#R42" rid="R42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881214">42</a></sup> Furthermore, these associations were not observed in subjects treated with placebo and statin, lending support for these associations with fenofibrate drug response. Although several GWAS findings were replicated in two functional studies, those studies were conducted using a mouse model that may not be applicable to human subjects, and not all genes with GWAS associations here were available for gene expression follow-up. Additionally, gene expression may not be the most relevant mechanism, as numerous ways exist for SNPs to impact drug response. Future studies will require larger cohorts and further functional work in relevant tissues to elucidate the pathways in which fenofibrate and PPARα alter lipid concentrations.</p><p id="P18" class="p p-last">We have identified novel common variants in black subjects located in several genes (e.g., <em>SMAD3</em> and <em>IPO11</em>) and rare variants (e.g., <em>HSD17B13</em>) that explain lipid variation in response to fenofibrate treatment in individuals with T2D treated with statins. These findings were further supported by changes in gene expression in mice and provide novel findings that explain variation in fenofibrate lipid response in individuals with T2D.</p></div><div id="S6" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S6title">MATERIALS AND METHODS</h2><div id="S7" class="sec sec-first"><h3 id="S7title">Study participants</h3><p id="P19" class="p p-first-last">The ACCORD trial (clinicaltrials.gov-<a id="__tag_677881289" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00000620" ref="reftype=extlink-clinical-trial&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00000620","term_id":"NCT00000620"}}</span>NCT00000620</a>) was a double 2 × 2 factorial design, consisting of 10,251 recruited subjects with T2D and either a history of CVD or at least two known risk factors for CVD, such as documented atherosclerosis, albuminuria, dyslipidemia, hypertension, smoking, or obesity.<sup><a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881217">7</a></sup> Subjects were randomized to either intensive or standard glycemia treatment strategies (targeting HbA1c &lt;6.0 vs. HbA1c between 7.0 and 7.9). Over 80% of subjects in the ACCORD study consented to being genotyped. There were 5,518 subjects who were further randomized to intensive vs. standard lipid management (fenofibrate vs. placebo, with all subjects on simvastatin). Each ACCORD participant provided written informed consent using procedures reviewed and approved by each clinical site’s local institutional review board and based on a template provided by the study group that was approved and subsequently centrally monitored by the Coordinating Center and the National Heart, Lung, and Blood Institute (IRB: FWA00003429). Entry criteria and additional information about the lipid subtrial and patient selection are described in the <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Material</a> online. As in the prior ACCORD and GOLDN meta-analyses, fenofibrate lipid response was calculated as: 
</p><div class="disp-formula" id="FD1"><div class="f"><span class="MathJax_Preview"><math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1" display="block" overflow="scroll"><mi mathvariant="italic">phenotype</mi><mo>=</mo><msub><mi mathvariant="italic">log</mi><mn>10</mn></msub><mrow><mo>(</mo><mfrac><mi>a</mi><mi>b</mi></mfrac><mo>)</mo></mrow></math></span><script type="math/mml"><math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1" display="block" overflow="scroll"><mi mathvariant="italic">phenotype</mi><mo>=</mo><msub><mi mathvariant="italic">log</mi><mn>10</mn></msub><mrow><mo>(</mo><mfrac><mi>a</mi><mi>b</mi></mfrac><mo>)</mo></mrow></math></script></div></div><p> where <em>a</em> is the pretreatment measurement of HDL, LDL, TC, or TG, and <em>b</em> is the on-treatment measurement of HDL, LDL, TC, or TG. After subsetting patients from the lipid subtrial based on consent, genotyping, drug response criteria, and quality control (see below) of DNAs extracted from these samples, the population for the current study included 1,264 subjects. These subjects included individuals that self-identified as white, black, Hispanic, Asian, and other.</p></div><div id="S8" class="sec"><h3 id="S8title">Genotyping and quality control</h3><p id="P20" class="p p-first-last">Genomic DNA extraction and cell preparations are described in the <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Material</a>. Genomewide genotyping was performed in two independent laboratories on different platforms: 6,085 unique samples, composed of those ACCORD participants who consented to genetic studies conducted by any investigator, were genotyped at the University of Virginia on Illumina HumanOmniExpressExome-8 version 1.0 chips (set 1)<sup><a href="#R43" rid="R43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881230">43</a></sup>; 8,174 unique samples, including the above 6,085 samples plus 2,089 samples from ACCORD participants who consented to genetic studies only if conducted by ACCORD investigators were genotyped at the University of North Carolina on Affymetrix Axiom Biobank1 chips (set 2). Additional information regarding the merging of set 1 and set 2, imputation, and quality control can be found in the <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Material</a>.</p></div><div id="S9" class="sec"><h3 id="S9title">Covariate selection</h3><p id="P21" class="p p-first-last">Here, we take a combined approach to variable selection to address potential confounding variables. A substantial proportion of the cohort was taking lipid-lowering medications at the time baseline lipid measurements were taken (e.g., 63% were on a statin prior to entering the trial). Statin, additional concomitant medications, and nondrug covariates (e.g., age, gender, body mass index, and smoking status) were incorporated into the model, as previously described in Graham &amp; Rotroff <em>et al</em>.<sup><a href="#R44" rid="R44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881192">44</a></sup> and is described in the <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Material</a>. A full list of covariate names and descriptions can be found in <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table S1</a>.</p></div><div id="S10" class="sec"><h3 id="S10title">Common variant analysis</h3><p id="P22" class="p p-first-last">Association between a phenotype, selected, and forced covariates, and a single common variant (MAF &gt;3%) was tested with an additive genetic model using linear regression in the PLINK software for genotyped variants.<sup><a href="#R45" rid="R45" class=" bibr popnode">45</a></sup> Imputed variants were tested using a linear regression model in the statistical programming language, R, where <em>g<sub>i</sub></em>=<em>p<sub>i</sub></em>(<em>Aa</em>) + 2<em>p<sub>i</sub></em>(<em>aa</em>) is the dosage score computed from the posterior probabilities for genotypes <em>Aa</em> and <em>aa</em>.<sup><a href="#R45" rid="R45" class=" bibr popnode">45</a>,<a href="#R46" rid="R46" class=" bibr popnode">46</a></sup> For SNPs that were only genotyped in set 1 subjects and were imputed in set 2 subjects, association tests results were combined by meta-analysis using PLINK.<sup><a href="#R45" rid="R45" class=" bibr popnode">45</a></sup> Tables and figures specify whether each SNP association was genotyped, imputed, or meta-analyzed. The results from the common variant tests were considered statistically significant based on a <em>P</em> &lt; 5 × 10<sup>−8</sup> and <em>P</em> &lt; 1 × 10<sup>−6</sup> was considered the threshold for suggestive significance. To maximize the likelihood of finding genes expression altered by fenofibrate exposure, a more liberal threshold of <em>P</em> &lt; 1 × 10<sup>−5</sup> was used only for functional validation, as described below. Additional information regarding the common variant analysis can be found in the <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Material</a>.</p></div><div id="S11" class="sec"><h3 id="S11title">Rare variant analysis</h3><p id="P23" class="p p-first-last">We implemented a suite of five rare variant tests that can be divided into two classes, burden and nonburden approaches, as previously described.<sup><a href="#R47" rid="R47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881232">47</a></sup> Burden tests collapse a set of rare variants from a gene into a single variable, which is then tested for association with a phenotype. However, simple burden tests do not account for the direction (positive or negative association) of a rare variant effect.<sup><a href="#R48" rid="R48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881225">48</a></sup> One nonburden rare variant test that allows for different directions and magnitudes of effects for each variant is the sequence kernel association test (SKAT).<sup><a href="#R48" rid="R48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881206">48</a></sup> The balance between SKAT and burden tests was addressed using the optimal test, SKAT-O, which aims to optimize the combination of the two approaches. Gene annotations were performed using Ensemble (GRCh37.p13), which mapped the 232,678 rare variants (MAF ≤3%) genotyped in set 1 subjects to 17,081 total genes. Subsequently, the combined <em>P</em> value was corrected for multiple comparisons with an false discovery rate (FDR) approach using the R package, <em>qvalue</em> (version 1.36.0) and <em>q</em> &lt; 0.2 was considered to be statistically significant.<sup><a href="#R49" rid="R49" class=" bibr popnode">49</a></sup> Additional details regarding the rare variant analysis implemented here can be found in Marvel &amp; Rotroff <em>et al</em>.<sup><a href="#R47" rid="R47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881234">47</a></sup> and the <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Material</a>.</p></div><div id="S12" class="sec"><h3 id="S12title">Placebo analysis</h3><p id="P24" class="p p-first-last">Study protocols for those receiving placebo in the lipid subtrial of ACCORD were the same as the fibrate arm of the trial, except that placebo was administered instead of fenofibrate. To confirm that the results were associated with fibrate and not placebo or statin, we conducted common and rare variant associations using the same analysis workflow, covariates, and models as described above for all races combined (<em>n</em> = 1,336), white (<em>n</em> = 908), and black subjects (<em>n</em> = 186). The results from the placebo analysis are included along with the fenofibrate results in <a href="/pmc/articles/PMC5828950/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Tables (1</span></a>–<a href="/pmc/articles/PMC5828950/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>3</span></a>) and <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Tables S14 and S15</a>.</p></div><div id="S13" class="sec sec-last"><h3 id="S13title">Mouse gene expression validation</h3><p id="P25" class="p p-first-last">We investigated gene expression changes in wild-type C57BL/6J mice administered fenofibrate compared with mice administered vehicle control, as described by Liu <em>et al</em>.<sup><a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677881213">20</a></sup> to provide additional validation for common and rare variant associations with fenofibrate lipid response identified (REP1). To maximize the likelihood of finding genes with expression changes due to fenofibrate exposure, we expanded the genes chosen for evaluation to include those with common variant associations <em>P</em> &lt; 1 × 10<sup>−5</sup>, where the variants were annotated as being in genes according to the National Center for Biotechnology Information database using the <em>rsnps</em> package,<sup><a href="#R50" rid="R50" class=" bibr popnode">50</a></sup> and genes with <em>q</em> &lt; 0.2 in the rare variant tests. An additional follow-up replication study was conducted at the University of Kentucky (REP2) to try and further validate the findings in REP1 and include additional genes identified in the ACCORD analysis that were not available in the previously published data in REP1. Additional details regarding the mouse gene expression methods can be found in the <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Material</a>. Furthermore, the gene expression results of <em>Rab27b</em>, a gene identified in an interim analysis of only set 2 data, and was not significant after merging set 1 and set 2 data (<em>q</em> &gt; 0.2) is presented in the <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Material</a>.</p></div></div><div id="unreferenced-ft" class="tsec sec headless whole_rhythm"><div class="unreferenced">​
                    <!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC5828950/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139874146348384" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is nihms921427f3.jpg" title="An external file that holds a picture, illustration, etc.
Object name is nihms921427f3.jpg" src="/pmc/articles/PMC5828950/bin/nihms921427f3.jpg"></div></a><div id="largeobj_idm139874146348384" class="largeobj-link align_right" style=""><a href="/pmc/articles/PMC5828950/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"></a><a target="object" href="/pmc/articles/PMC5828950/figure/F3/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC5828950/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p9">Gene expression in mice exposed to fenofibrate vs. vehicle control in (<strong>a</strong>) adipose tissue, (<strong>b</strong>) skeletal muscle, and (<strong>c</strong>) liver tissue. ***False discovery rate (FDR) <em>P</em> value &lt; 0.01; **FDR <em>P</em> value &lt; 0.1; *FDR <em>P</em> value &lt; 0.2. [Color figure can be viewed at <a href="http://wileyonlinelibrary.com" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">wileyonlinelibrary.com</a>]</p></div></div></div><div class="boxed-text-box whole_rhythm hide-overflow" id="BX1"><div class="caption"><h3 id="idm139874148990176title">Study Highlights</h3></div><div class="sec" id="S16"><h3 id="S16title">WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC?</h3><ul class="simple" style="list-style-type:none" id="L1"><!--
list-behavior=simple
prefix-word=
mark-type=none
max-label-size=0
--><li><p id="__p20">☑ Fibrates are a class of drugs commonly prescribed to lower serum lipid levels; however, individual variation in response to fenofibrates has been observed and drivers of this variation are not well understood.</p></li></ul></div><div class="sec" id="S17"><h3 id="S17title">WHAT QUESTION DID THIS STUDY ADDRESS?</h3><ul class="simple" style="list-style-type:none" id="L2"><!--
list-behavior=simple
prefix-word=
mark-type=none
max-label-size=0
--><li><p id="__p21">☑ Here, we evaluate the association of common and rare genetic variants with variation in response to fenofibrate treatment in individuals with T2D.</p></li></ul></div><div class="sec" id="S18"><h3 id="S18title">WHAT THIS STUDY ADDS TO OUR KNOWLEDGE</h3><ul class="simple" style="list-style-type:none" id="L3"><!--
list-behavior=simple
prefix-word=
mark-type=none
max-label-size=0
--><li><p id="__p22">☑ We demonstrate novel associations of common genetic variants in <em>SMAD3</em> and <em>IPO11</em> genes in black subjects, and rare variants in <em>AKR7A3</em> and <em>HSD17B13</em> in white subjects were associated with variation in fibrate lipid response. We then support these findings using gene expression in a mouse model.</p></li></ul></div><div class="sec" id="S19"><h3 id="S19title">HOW THIS MIGHT CHANGE CLINICAL PHARMACOLOGY OR TRANSLATIONAL SCIENCE</h3><ul class="simple" style="list-style-type:none" id="L4"><!--
list-behavior=simple
prefix-word=
mark-type=none
max-label-size=0
--><li><p id="__p23">☑ Our findings highlight genetic variants in TGF-β and NRF2 signaling pathways that may influence fenofibrate effects on dyslipidemia in individuals with T2D. This insight could help to identify patients for more targeted treatment strategies or elucidate novel therapeutic targets.</p></li></ul></div></div></div></div><div id="S14" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S14title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><h4>Supp Info</h4><div class="sup-box half_rhythm" id="d36e1498"><a href="/pmc/articles/PMC5828950/bin/NIHMS921427-supplement-Supp_Info.docx" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(2.8M, docx)</sup></div></div></div><div id="S15" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S15title">Acknowledgments</h2><div class="sec"><p id="__p1">This research was supported by a National Heart, Lung, and Blood Institute grant to the University of North Carolina at Chapel Hill (5R01HL110380-04) and R01 HL110400 to the Joslin Diabetes Center and the University of Virginia. Dr Ginsberg received support from National Heart, Lung, and Blood Institute R01 HL110418.</p></div></div><div id="idm139874191372144" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139874191372144title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN2"></p><p id="__p2" class="p p-first-last">Additional <a href="#SD1" rid="SD1" class=" supplementary-material">Supporting Information</a> may be found in the online version of this article.</p><p></p><p class="fn sec" id="FN3"></p><p id="__p3" class="p p-first"><strong>CONFLICT OF INTEREST</strong></p><p id="__p4" class="p p-last">The authors have no conflicts of interest to disclose.</p><p></p><div><p id="__p5" class="p p-first"><strong>AUTHORSHIP CONTRIBUTION</strong></p>D.M.R., S.S.P., J.R.J., G.A.G., H.N.G., H.L.M., J.B.B., M.J.W., and A.M.R. wrote the paper. D.M.R., A.P., A.G., G.A.G., A.D., J.C.M., H.L.M., J.B.B., M.J.W., and A.M.R. designed the research. D.M.R., S.S.P., J.R.J., T.M.H., H.S.S., H.G., A.D., M.J.W., and A.M.R. performed the research. D.M.R., S.W.M., S.S.P., A.P., A.S., H.S.S., M.L.M., and J.C.M. analyzed the data.</div></div></div><div id="idm139874185346832" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139874185346832title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">WHO; World Heart Federation; World Stroke Organization, editor. <span class="ref-journal">Global atlas on cardiovascular disease prevention and control Policies, strategies and interventions.</span> World Health Organization; 2011.  2011. &lt; <a href="http://www.who.int/cardiovascular_diseases/publications/atlas_cvd/en/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.who.int/cardiovascular_diseases/publications/atlas_cvd/en/</a>&gt;. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Global+atlas+on+cardiovascular+disease+prevention+and+control+Policies,+strategies+and+interventions&amp;publication_year=2011&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Writing Group Members et al.  Heart Disease and Stroke Statistics-2016 update: a report from the American Heart Association. <span><span class="ref-journal">Circulation. </span>2016;<span class="ref-vol">133</span>:e38–e360.</span> [<a href="/pubmed/26673558" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Heart+Disease+and+Stroke+Statistics-2016+update:+a+report+from+the+American+Heart+Association&amp;volume=133&amp;publication_year=2016&amp;pages=e38-e360&amp;pmid=26673558&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">Saha SA, Kizhakepunnur LG, Bahekar A, Arora RR. The role of fibrates in the prevention of cardiovascular disease–a pooled meta-analysis of long-term randomized placebo-controlled clinical trials. <span><span class="ref-journal">Am Heart J. </span>2007;<span class="ref-vol">154</span>:943–953.</span> [<a href="/pubmed/17967602" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+Heart+J&amp;title=The+role+of+fibrates+in+the+prevention+of+cardiovascular+disease–a+pooled+meta-analysis+of+long-term+randomized+placebo-controlled+clinical+trials&amp;author=SA+Saha&amp;author=LG+Kizhakepunnur&amp;author=A+Bahekar&amp;author=RR+Arora&amp;volume=154&amp;publication_year=2007&amp;pages=943-953&amp;pmid=17967602&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Jun M, et al.  Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. <span><span class="ref-journal">Lancet. </span>2010;<span class="ref-vol">375</span>:1875–1884.</span> [<a href="/pubmed/20462635" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Effects+of+fibrates+on+cardiovascular+outcomes:+a+systematic+review+and+meta-analysis&amp;author=M+Jun&amp;volume=375&amp;publication_year=2010&amp;pages=1875-1884&amp;pmid=20462635&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Stone NJ, et al.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. <span><span class="ref-journal">J Am Coll Cardiol. </span>2014;<span class="ref-vol">63</span>(25 Pt B):2889–2934.</span> [<a href="/pubmed/24239923" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Coll+Cardiol&amp;title=2013+ACC/AHA+guideline+on+the+treatment+of+blood+cholesterol+to+reduce+atherosclerotic+cardiovascular+risk+in+adults:+a+report+of+the+American+College+of+Cardiology/American+Heart+Association+Task+Force+on+Practice+Guidelines&amp;author=NJ+Stone&amp;volume=63&amp;issue=25+Pt+B&amp;publication_year=2014&amp;pages=2889-2934&amp;pmid=24239923&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Berglund L, et al.  Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2012;<span class="ref-vol">97</span>:2969–2989.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3431581/">PMC free article</a>]</span> [<a href="/pubmed/22962670" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab&amp;title=Evaluation+and+treatment+of+hypertriglyceridemia:+an+Endocrine+Society+clinical+practice+guideline&amp;author=L+Berglund&amp;volume=97&amp;publication_year=2012&amp;pages=2969-2989&amp;pmid=22962670&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">ACCORD Study Group et al.  Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. <span><span class="ref-journal">Am J Cardiol. </span>2007;<span class="ref-vol">99</span>:27i–33i.</span> [<a href="/pubmed/17599422" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Cardiol&amp;title=Action+to+Control+Cardiovascular+Risk+in+Diabetes+(ACCORD)+trial:+design+and+methods&amp;volume=99&amp;publication_year=2007&amp;pages=27i-33i&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Goff DC, Jr, et al.  Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. <span><span class="ref-journal">Am J Cardiol. </span>2007;<span class="ref-vol">99</span>:4i–20i.</span> [<a href="/pubmed/17599424" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Cardiol&amp;title=Prevention+of+cardiovascular+disease+in+persons+with+type+2+diabetes+mellitus:+current+knowledge+and+rationale+for+the+Action+to+Control+Cardiovascular+Risk+in+Diabetes+(ACCORD)+trial&amp;author=DC+Goff&amp;volume=99&amp;publication_year=2007&amp;pages=4i-20i&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">ACCORD Study Group et al.  Effects of intensive blood-pressure control in type 2 diabetes mellitus. <span><span class="ref-journal">N Engl J Med. </span>2010;<span class="ref-vol">362</span>:1575–1585.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4123215/">PMC free article</a>]</span> [<a href="/pubmed/20228401" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Effects+of+intensive+blood-pressure+control+in+type+2+diabetes+mellitus&amp;volume=362&amp;publication_year=2010&amp;pages=1575-1585&amp;pmid=20228401&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Gerstein HC, et al.  Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. <span><span class="ref-journal">Am J Cardiol. </span>2007;<span class="ref-vol">99</span>:34i–43i.</span> [<a href="/pubmed/17599423" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Cardiol&amp;title=Glycemia+treatment+strategies+in+the+Action+to+Control+Cardiovascular+Risk+in+Diabetes+(ACCORD)+trial&amp;author=HC+Gerstein&amp;volume=99&amp;publication_year=2007&amp;pages=34i-43i&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Ginsberg HN, et al.  Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. <span><span class="ref-journal">Am J Cardiol. </span>2007;<span class="ref-vol">99</span>:56i–67i.</span> [<a href="/pubmed/17599426" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Cardiol&amp;title=Evolution+of+the+lipid+trial+protocol+of+the+Action+to+Control+Cardiovascular+Risk+in+Diabetes+(ACCORD)+trial&amp;author=HN+Ginsberg&amp;volume=99&amp;publication_year=2007&amp;pages=56i-67i&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Willer CJ, et al.  Discovery and refinement of loci associated with lipid levels. <span><span class="ref-journal">Nat Genet. </span>2013;<span class="ref-vol">45</span>:1274–1283.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3838666/">PMC free article</a>]</span> [<a href="/pubmed/24097068" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Discovery+and+refinement+of+loci+associated+with+lipid+levels&amp;author=CJ+Willer&amp;volume=45&amp;publication_year=2013&amp;pages=1274-1283&amp;pmid=24097068&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">ACCORD Study Group et al.  Effects of combination lipid therapy in type 2 diabetes mellitus. <span><span class="ref-journal">N Engl J Med. </span>2010;<span class="ref-vol">362</span>:1563–1574.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2879499/">PMC free article</a>]</span> [<a href="/pubmed/20228404" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Effects+of+combination+lipid+therapy+in+type+2+diabetes+mellitus&amp;volume=362&amp;publication_year=2010&amp;pages=1563-1574&amp;pmid=20228404&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Irvin MR, et al.  A genome-wide study of lipid response to fenofibrate in Caucasians: a combined analysis of the GOLDN and ACCORD studies. <span><span class="ref-journal">Pharmacogenet Genomics. </span>2016;<span class="ref-vol">26</span>:324–333.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4986826/">PMC free article</a>]</span> [<a href="/pubmed/27002377" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenet+Genomics&amp;title=A+genome-wide+study+of+lipid+response+to+fenofibrate+in+Caucasians:+a+combined+analysis+of+the+GOLDN+and+ACCORD+studies&amp;author=MR+Irvin&amp;volume=26&amp;publication_year=2016&amp;pages=324-333&amp;pmid=27002377&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Keech A, et al.  Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. <span><span class="ref-journal">Lancet. </span>2005;<span class="ref-vol">366</span>:1849–1861.</span> [<a href="/pubmed/16310551" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Effects+of+long-term+fenofibrate+therapy+on+cardiovascular+events+in+9795+people+with+type+2+diabetes+mellitus+(the+FIELD+study):+randomised+controlled+trial&amp;author=A+Keech&amp;volume=366&amp;publication_year=2005&amp;pages=1849-1861&amp;pmid=16310551&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Aslibekyan S, et al.  Variants identified in a GWAS meta-analysis for blood lipids are associated with the lipid response to fenofibrate. <span><span class="ref-journal">PLoS One. </span>2012;<span class="ref-vol">7</span>:e48663.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3485381/">PMC free article</a>]</span> [<a href="/pubmed/23119086" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Variants+identified+in+a+GWAS+meta-analysis+for+blood+lipids+are+associated+with+the+lipid+response+to+fenofibrate&amp;author=S+Aslibekyan&amp;volume=7&amp;publication_year=2012&amp;pages=e48663&amp;pmid=23119086&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Irvin MR, et al.  Rare PPARA variants and extreme response to fenofibrate in the Genetics of Lipid-Lowering Drugs and Diet Network Study. <span><span class="ref-journal">Pharmacogenet Genomics. </span>2012;<span class="ref-vol">22</span>:367–372.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3325369/">PMC free article</a>]</span> [<a href="/pubmed/22336959" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenet+Genomics&amp;title=Rare+PPARA+variants+and+extreme+response+to+fenofibrate+in+the+Genetics+of+Lipid-Lowering+Drugs+and+Diet+Network+Study&amp;author=MR+Irvin&amp;volume=22&amp;publication_year=2012&amp;pages=367-372&amp;pmid=22336959&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Smith JA, et al.  The genetic architecture of fasting plasma triglyceride response to fenofibrate treatment. <span><span class="ref-journal">Eur J Hum Genet. </span>2008;<span class="ref-vol">16</span>:603–613.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2546577/">PMC free article</a>]</span> [<a href="/pubmed/18212815" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Hum+Genet&amp;title=The+genetic+architecture+of+fasting+plasma+triglyceride+response+to+fenofibrate+treatment&amp;author=JA+Smith&amp;volume=16&amp;publication_year=2008&amp;pages=603-613&amp;pmid=18212815&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Gao F, Ballantyne C, Ma L, Virani SS, Keinan A, Brautbar A. Rare LPL gene variants attenuate triglyceride reduction and HDL cholesterol increase in response to fenofibric acid therapy in individuals with mixed dyslipidemia. <span><span class="ref-journal">Atherosclerosis. </span>2014;<span class="ref-vol">234</span>:249–253.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4078400/">PMC free article</a>]</span> [<a href="/pubmed/24704626" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Atherosclerosis&amp;title=Rare+LPL+gene+variants+attenuate+triglyceride+reduction+and+HDL+cholesterol+increase+in+response+to+fenofibric+acid+therapy+in+individuals+with+mixed+dyslipidemia&amp;author=F+Gao&amp;author=C+Ballantyne&amp;author=L+Ma&amp;author=SS+Virani&amp;author=A+Keinan&amp;volume=234&amp;publication_year=2014&amp;pages=249-253&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Liu X, et al.  ABCD2 alters peroxisome proliferator-activated receptor α signaling in vitro, but does not impair responses to fenofibrate therapy in a mouse model of diet-induced obesity. <span><span class="ref-journal">Mol Pharmacol. </span>2014;<span class="ref-vol">86</span>:505–513.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4201141/">PMC free article</a>]</span> [<a href="/pubmed/25123288" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;title=ABCD2+alters+peroxisome+proliferator-activated+receptor+α+signaling+in+vitro,+but+does+not+impair+responses+to+fenofibrate+therapy+in+a+mouse+model+of+diet-induced+obesity&amp;author=X+Liu&amp;volume=86&amp;publication_year=2014&amp;pages=505-513&amp;pmid=25123288&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">HPS2-THRIVE Collaborative Group et al.  Effects of extended-release niacin with laropiprant in high-risk patients. <span><span class="ref-journal">N Engl J Med. </span>2014;<span class="ref-vol">371</span>:203–212.</span> [<a href="/pubmed/25014686" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Effects+of+extended-release+niacin+with+laropiprant+in+high-risk+patients&amp;volume=371&amp;publication_year=2014&amp;pages=203-212&amp;pmid=25014686&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">Taylor F, et al.  Statins for the primary prevention of cardiovascular disease. <span><span class="ref-journal">Cochrane Library. </span>2013</span> &lt; <a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004816.pub5/pdf" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004816.pub5/pdf</a>&gt;.</span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Elias PM, Williams ML, Holleran WM, Jiang YJ, Schmuth M. Thematic review series: skin lipids. Pathogenesis of permeability barrier abnormalities in the ichthyoses: inherited disorders of lipid metabolism. <span><span class="ref-journal">J Lipid Res. </span>2008;<span class="ref-vol">49</span>:697–714.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2844331/">PMC free article</a>]</span> [<a href="/pubmed/18245815" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Lipid+Res&amp;title=Thematic+review+series:+skin+lipids.+Pathogenesis+of+permeability+barrier+abnormalities+in+the+ichthyoses:+inherited+disorders+of+lipid+metabolism&amp;author=PM+Elias&amp;author=ML+Williams&amp;author=WM+Holleran&amp;author=YJ+Jiang&amp;author=M+Schmuth&amp;volume=49&amp;publication_year=2008&amp;pages=697-714&amp;pmid=18245815&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">Cowart LA, et al.  The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands. <span><span class="ref-journal">J Biol Chem. </span>2002;<span class="ref-vol">277</span>:35105–35112.</span> [<a href="/pubmed/12124379" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=The+CYP4A+isoforms+hydroxylate+epoxyeicosatrienoic+acids+to+form+high+affinity+peroxisome+proliferator-activated+receptor+ligands&amp;author=LA+Cowart&amp;volume=277&amp;publication_year=2002&amp;pages=35105-35112&amp;pmid=12124379&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">Plafker KS, Plafker SM. The ubiquitin-conjugating enzyme UBE2E3 and its import receptor importin-11 regulate the localization and activity of the antioxidant transcription factor NRF2. <span><span class="ref-journal">Mol Biol Cell. </span>2015;<span class="ref-vol">26</span>:327–338.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4294679/">PMC free article</a>]</span> [<a href="/pubmed/25378586" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Biol+Cell&amp;title=The+ubiquitin-conjugating+enzyme+UBE2E3+and+its+import+receptor+importin-11+regulate+the+localization+and+activity+of+the+antioxidant+transcription+factor+NRF2&amp;author=KS+Plafker&amp;author=SM+Plafker&amp;volume=26&amp;publication_year=2015&amp;pages=327-338&amp;pmid=25378586&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Huang J, Tabbi-Anneni I, Gunda V, Wang L. Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism. <span><span class="ref-journal">Am J Physiol Gastrointest Liver Physiol. </span>2010;<span class="ref-vol">299</span>:G1211–G1221.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3006243/">PMC free article</a>]</span> [<a href="/pubmed/20930048" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol+Gastrointest+Liver+Physiol&amp;title=Transcription+factor+Nrf2+regulates+SHP+and+lipogenic+gene+expression+in+hepatic+lipid+metabolism&amp;author=J+Huang&amp;author=I+Tabbi-Anneni&amp;author=V+Gunda&amp;author=L+Wang&amp;volume=299&amp;publication_year=2010&amp;pages=G1211-G1221&amp;pmid=20930048&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="element-citation">Chen WD, Zhang Y. Regulation of aldo-keto reductases in human diseases. <span><span class="ref-journal">Front Pharmacol. </span>2012;<span class="ref-vol">3</span>:35.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3297832/">PMC free article</a>]</span> [<a href="/pubmed/22408622" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front+Pharmacol&amp;title=Regulation+of+aldo-keto+reductases+in+human+diseases&amp;author=WD+Chen&amp;author=Y+Zhang&amp;volume=3&amp;publication_year=2012&amp;pages=35&amp;pmid=22408622&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="element-citation">Ahmed MM, et al.  Aldo-keto reductase-7A protects liver cells and tissues from acetaminophen-induced oxidative stress and hepatotoxicity. <span><span class="ref-journal">Hepatology. </span>2011;<span class="ref-vol">54</span>:1322–1332.</span> [<a href="/pubmed/21688283" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=Aldo-keto+reductase-7A+protects+liver+cells+and+tissues+from+acetaminophen-induced+oxidative+stress+and+hepatotoxicity&amp;author=MM+Ahmed&amp;volume=54&amp;publication_year=2011&amp;pages=1322-1332&amp;pmid=21688283&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="element-citation">Park JS, Kang DH, Lee DH, Bae SH. Fenofibrate activates Nrf2 through p62-dependent Keap1 degradation. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2015;<span class="ref-vol">465</span>:542–547.</span> [<a href="/pubmed/26282199" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;title=Fenofibrate+activates+Nrf2+through+p62-dependent+Keap1+degradation&amp;author=JS+Park&amp;author=DH+Kang&amp;author=DH+Lee&amp;author=SH+Bae&amp;volume=465&amp;publication_year=2015&amp;pages=542-547&amp;pmid=26282199&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="element-citation">Tan CK, Chong HC, Tan EH, Tan NS. Getting ‘Smad’ about obesity and diabetes. <span><span class="ref-journal">Nutr Diabetes. </span>2012;<span class="ref-vol">2</span>:e29.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3341711/">PMC free article</a>]</span> [<a href="/pubmed/23449528" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nutr+Diabetes&amp;title=Getting+‘Smad’+about+obesity+and+diabetes&amp;author=CK+Tan&amp;author=HC+Chong&amp;author=EH+Tan&amp;author=NS+Tan&amp;volume=2&amp;publication_year=2012&amp;pages=e29&amp;pmid=23449528&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31. <span class="element-citation">Tan CK, et al.  Smad3 deficiency in mice protects against insulin resistance and obesity induced by a high-fat diet. <span><span class="ref-journal">Diabetes. </span>2011;<span class="ref-vol">60</span>:464–476.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3028346/">PMC free article</a>]</span> [<a href="/pubmed/21270259" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Smad3+deficiency+in+mice+protects+against+insulin+resistance+and+obesity+induced+by+a+high-fat+diet&amp;author=CK+Tan&amp;volume=60&amp;publication_year=2011&amp;pages=464-476&amp;pmid=21270259&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">32. <span class="element-citation">Zhu B, Zhai J, Zhu H, Kyprianou N. Prohibitin regulates TGF-beta induced apoptosis as a downstream effector of Smad-dependent and -independent signaling. <span><span class="ref-journal">Prostate. </span>2010;<span class="ref-vol">70</span>:17–26.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3762596/">PMC free article</a>]</span> [<a href="/pubmed/19725029" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Prostate&amp;title=Prohibitin+regulates+TGF-beta+induced+apoptosis+as+a+downstream+effector+of+Smad-dependent+and+-independent+signaling&amp;author=B+Zhu&amp;author=J+Zhai&amp;author=H+Zhu&amp;author=N+Kyprianou&amp;volume=70&amp;publication_year=2010&amp;pages=17-26&amp;pmid=19725029&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">33. <span class="element-citation">Kintscher U, et al.  PPARalpha inhibits TGF-beta-induced beta5 integrin transcription in vascular smooth muscle cells by interacting with Smad4. <span><span class="ref-journal">Circ Res. </span>2002;<span class="ref-vol">91</span>:e35–e44.</span> [<a href="/pubmed/12456495" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circ+Res&amp;title=PPARalpha+inhibits+TGF-beta-induced+beta5+integrin+transcription+in+vascular+smooth+muscle+cells+by+interacting+with+Smad4&amp;author=U+Kintscher&amp;volume=91&amp;publication_year=2002&amp;pages=e35-e44&amp;pmid=12456495&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R34">34. <span class="element-citation">Hong YA, et al.  Fenofibrate improves renal lipotoxicity through activation of AMPK-PGC-1α in db/db mice. <span><span class="ref-journal">PLoS One. </span>2014;<span class="ref-vol">9</span>:e96147.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4011795/">PMC free article</a>]</span> [<a href="/pubmed/24801481" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Fenofibrate+improves+renal+lipotoxicity+through+activation+of+AMPK-PGC-1α+in+db/db+mice&amp;author=YA+Hong&amp;volume=9&amp;publication_year=2014&amp;pages=e96147&amp;pmid=24801481&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R35">35. <span class="element-citation">Yan TT, et al.  Sex-specific association of rs16996148 SNP in the NCAN/CILP2/PBX4 and serum lipid levels in the Mulao and Han populations. <span><span class="ref-journal">Lipids Health Dis. </span>2011;<span class="ref-vol">10</span>:248.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3274493/">PMC free article</a>]</span> [<a href="/pubmed/22208664" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lipids+Health+Dis&amp;title=Sex-specific+association+of+rs16996148+SNP+in+the+NCAN/CILP2/PBX4+and+serum+lipid+levels+in+the+Mulao+and+Han+populations&amp;author=TT+Yan&amp;volume=10&amp;publication_year=2011&amp;pages=248&amp;pmid=22208664&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R36">36. <span class="element-citation">Lusis AJ, Pajukanta P. A treasure trove for lipoprotein biology. <span><span class="ref-journal">Nat Genet. </span>2008;<span class="ref-vol">40</span>:129–130.</span> [<a href="/pubmed/18227868" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=A+treasure+trove+for+lipoprotein+biology&amp;author=AJ+Lusis&amp;author=P+Pajukanta&amp;volume=40&amp;publication_year=2008&amp;pages=129-130&amp;pmid=18227868&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R37">37. <span class="element-citation">Kathiresan S, et al.  Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. <span><span class="ref-journal">Nat Genet. </span>2008;<span class="ref-vol">40</span>:189–197.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2682493/">PMC free article</a>]</span> [<a href="/pubmed/18193044" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Six+new+loci+associated+with+blood+low-density+lipoprotein+cholesterol,+high-density+lipoprotein+cholesterol+or+triglycerides+in+humans&amp;author=S+Kathiresan&amp;volume=40&amp;publication_year=2008&amp;pages=189-197&amp;pmid=18193044&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R38">38. <span class="element-citation">Holmen OL, et al.  Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk. <span><span class="ref-journal">Nat Genet. </span>2014;<span class="ref-vol">46</span>:345–351.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4169222/">PMC free article</a>]</span> [<a href="/pubmed/24633158" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Systematic+evaluation+of+coding+variation+identifies+a+candidate+causal+variant+in+TM6SF2+influencing+total+cholesterol+and+myocardial+infarction+risk&amp;author=OL+Holmen&amp;volume=46&amp;publication_year=2014&amp;pages=345-351&amp;pmid=24633158&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R39">39. <span class="element-citation">Kurz T, et al.  The conserved protein DCN-1/Dcn1p is required for cullin neddylation in C. elegans and S. cerevisiae. <span><span class="ref-journal">Nature. </span>2005;<span class="ref-vol">435</span>:1257–1261.</span> [<a href="/pubmed/15988528" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=The+conserved+protein+DCN-1/Dcn1p+is+required+for+cullin+neddylation+in+C.+elegans+and+S.+cerevisiae&amp;author=T+Kurz&amp;volume=435&amp;publication_year=2005&amp;pages=1257-1261&amp;pmid=15988528&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R40">40. <span class="element-citation">Uhlén M, et al.  Proteomics. Tissue-based map of the human proteome. <span><span class="ref-journal">Science. </span>2015;<span class="ref-vol">347</span>:1260419.</span> [<a href="/pubmed/25613900" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Proteomics.+Tissue-based+map+of+the+human+proteome&amp;author=M+Uhlén&amp;volume=347&amp;publication_year=2015&amp;pages=1260419&amp;pmid=25613900&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R41">41. <span class="element-citation">Su W, et al.  Comparative proteomic study reveals 17β-HSD13 as a pathogenic protein in nonalcoholic fatty liver disease. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>2014;<span class="ref-vol">111</span>:11437–11442.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4128098/">PMC free article</a>]</span> [<a href="/pubmed/25028495" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;title=Comparative+proteomic+study+reveals+17β-HSD13+as+a+pathogenic+protein+in+nonalcoholic+fatty+liver+disease&amp;author=W+Su&amp;volume=111&amp;publication_year=2014&amp;pages=11437-11442&amp;pmid=25028495&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R42">42. <span class="element-citation">American Diabetes Association. Cardiovascular disease and risk management. <span><span class="ref-journal">Diabetes Care. </span>2017;<span class="ref-vol">40</span>(suppl 1):S75–S87.</span> [<a href="/pubmed/27979896" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes+Care&amp;title=Cardiovascular+disease+and+risk+management&amp;volume=40&amp;issue=suppl+1&amp;publication_year=2017&amp;pages=S75-S87&amp;pmid=27979896&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R43">43. <span class="element-citation">Shah HS, et al.  Genetic predictors of cardiovascular mortality during intensive glycemic control in type 2 diabetes: findings from the ACCORD Clinical Trial. <span><span class="ref-journal">Diabetes Care. </span>2016;<span class="ref-vol">39</span>:1915–1924.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5079609/">PMC free article</a>]</span> [<a href="/pubmed/27527847" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes+Care&amp;title=Genetic+predictors+of+cardiovascular+mortality+during+intensive+glycemic+control+in+type+2+diabetes:+findings+from+the+ACCORD+Clinical+Trial&amp;author=HS+Shah&amp;volume=39&amp;publication_year=2016&amp;pages=1915-1924&amp;pmid=27527847&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R44">44. <span class="element-citation">Graham HT, et al.  Incorporating concomitant medications into genome-wide analyses for the study of complex disease and drug response. <span><span class="ref-journal">Front Genet. </span>2016;<span class="ref-vol">7</span>:138.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5013254/">PMC free article</a>]</span> [<a href="/pubmed/27775101" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front+Genet&amp;title=Incorporating+concomitant+medications+into+genome-wide+analyses+for+the+study+of+complex+disease+and+drug+response&amp;author=HT+Graham&amp;volume=7&amp;publication_year=2016&amp;pages=138&amp;pmid=27775101&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R45">45. <span class="element-citation"><span><span class="ref-journal">Shaun Purcell PLINK version 1.07. </span>2009</span> &lt; <a href="http://pngu.mgh.harvard.edu/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://pngu.mgh.harvard.edu/</a>&gt;.</span></div><div class="ref-cit-blk half_rhythm" id="R46">46. <span class="element-citation">R Development Core Team. <span class="ref-journal">Team R: a language and environment for statistical computing.</span> R Foundation for Statistical Computing; Vienna, Austria: 2014.  URL  <a href="http://www.R-project.org/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.R-project.org/</a>. &lt; <a href="http://www.R-project.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.R-project.org</a>&gt;. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Team+R:+a+language+and+environment+for+statistical+computing&amp;publication_year=2014&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R47">47. <span class="element-citation">Marvel SW, et al.  Common and rare genetic markers of lipid variation in subjects with type 2 diabetes from the ACCORD clinical trial. <span><span class="ref-journal">PeerJ. </span>2017;<span class="ref-vol">5</span>:e3187.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5417062/">PMC free article</a>]</span> [<a href="/pubmed/28480134" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PeerJ&amp;title=Common+and+rare+genetic+markers+of+lipid+variation+in+subjects+with+type+2+diabetes+from+the+ACCORD+clinical+trial&amp;author=SW+Marvel&amp;volume=5&amp;publication_year=2017&amp;pages=e3187&amp;pmid=28480134&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R48">48. <span class="element-citation">Wu MC, Lee S, Cai T, Li Y, Boehnke M, Lin X. Rare-variant association testing for sequencing data with the sequence kernel association test. <span><span class="ref-journal">Am J Hum Genet. </span>2011;<span class="ref-vol">89</span>:82–93.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3135811/">PMC free article</a>]</span> [<a href="/pubmed/21737059" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=Rare-variant+association+testing+for+sequencing+data+with+the+sequence+kernel+association+test&amp;author=MC+Wu&amp;author=S+Lee&amp;author=T+Cai&amp;author=Y+Li&amp;author=M+Boehnke&amp;volume=89&amp;publication_year=2011&amp;pages=82-93&amp;pmid=21737059&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R49">49. <span class="element-citation">Storey JD. A direct approach to false discovery rates. <span><span class="ref-journal">J R Stat Soc Ser B Stat Methodol. </span>2002;<span class="ref-vol">64</span>(Pt 3):479–498.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+R+Stat+Soc+Ser+B+Stat+Methodol&amp;title=A+direct+approach+to+false+discovery+rates&amp;author=JD+Storey&amp;volume=64&amp;issue=Pt+3&amp;publication_year=2002&amp;pages=479-498&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R50">50. <span class="element-citation">Chamberlain S, Ushey K. <span><span class="ref-journal">rsnps: Get SNP (Single-Nucleotide Polymorphism) Data on the Web. </span>2015</span> &lt; <a href="https://CRAN.R-project.org/package=rsnps" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5828950&amp;issue-id=307392&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">https://CRAN.R-project.org/package=rsnps</a>&gt;.</span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm139874183967984title">Abstract</a></li><li><a href="#S1title">RESULTS</a></li><li><a href="#S5title">DISCUSSION</a></li><li><a href="#S6title">MATERIALS AND METHODS</a></li><li><a href="#S14title">Supplementary Material</a></li><li><a href="#S15title">Acknowledgments</a></li><li><a href="#idm139874191372144title">Footnotes</a></li><li><a href="#idm139874185346832title">References</a></li></ul></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC5828950/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC5828950/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC5828950/pdf/nihms921427.pdf">PDF (588K)</a></li> | <li><a href="#" data-citationid="PMC5828950" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5828950%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5828950%2F&amp;text=Genetic%20Variants%20in%20HSD17B3%2C%20SMAD3%2C%20and%20IPO11%20Impact%20Circulating%20Lipids%20in%20Response%20to%20Fenofibrate%20in%20Individuals%20With%20Type%202%20Diabetes" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5828950%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="28736931" data-aiid="5828950" data-aid="5828950" data-iid="307392" data-domainid="319" data-domain="nihpa" data-accid="PMC5828950" data-md5="fcb21305856462e11ec32086f35f6bc1"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T16:27:15-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal106&amp;ncbi_phid=CE8D05E3DD5A78D10000000004DD02E5&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5828950%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nihpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC5828950/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>